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CHAPTER 1
INTRODUCTION
1.1 BACKGROUND
The emerging area of nanotechnology includes the study of materials having
a characteristic length scale less than 100 nm and their applications. One
particularly exciting topic is the use of nanoscale magnetic materials for biomedical
application [1]. Many interesting properties of magnetic nanoparticles have been
investigated, and these studies have led to an expectation that these systems will
have applications in biomedicine. Magnetic nanoparticles may be useful for these
applications if they can be made biocompatible, stable, and biodegradable, possibly
by coating them with suitable materials to allow them to be attached to antibodies,
proteins and drugs. Generally, polysaccharides (like dextran) and polymers (like
poly ethylene glycol) are used for such coating.
Magnetic nanoparticles have the potential to be delivered to a specific region
in the body by applying an external magnetic field. For this use in vivo, one needs
large magnetizations for the magnetic nanoparticles so that they respond to
externally applied magnetic field at and above room temperature. Magnetite
(Fe3O4) and Maghemite (-Fe2O3) are suitable particles for many biomedical
applications, as they have bulk magnetization values of 82 emu/g and 75 emu/g
respectively [2], and are relatively non-toxic [3]. Because of thermal fluctuations,
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sufficiently small magnetic nanoparticles have no remanent magnetization at room
temperature. This minimizes the possibility of aggregation, which could have
harmful effects, and favors biological absorption and eventually the excretion of
particles by the body. These particles can be prepared as isolated particles or
dispersed in a carrier liquid, where they are called a “ferrofluid”. We have
investigated many physical properties of magnetic nanoparticles both in powder
and solution form. In addition to understanding the physics of these nanoparticles,
we have also investigated many biomedical applications of magnetic nanoparticles
including magnetic hyperthermia, drug delivery, radiation therapy, and as a
contrast agent in MRI.

1.2 MAGNETIC NANOPARTICLES
In ferromagnetic materials below the transition temperature the local
magnetic moments of atoms are ordered with parallel alignment . The interactions
producing this arrangement originate from the properties of the local moments and
are called the exchange interaction [4]. This exchange from the coulomb interaction
between two electrons and the fact that the wave function of two electrons must be
antisymmetric under the exchange of all electron coordinates, space and spin [5].
Inside a ferromagnetic material there are a number of regions having parallel spins.
These regions are called magnetic domains, and are illustrated in Figure 1.1.
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Figure 1.1: Magnetic domains
In each of these domains, a large number of atomic moments, typically 10 12 to 1015,
are aligned parallel so that the magnetization within the domain is almost
saturated [6]. However, the direction of this spin alignment varies from one domain
to another, and will be randomly oriented in the absence of an external magnetic
field. The formation of these domains is a consequence of minimizing the magnetic
free energy. Magnetic domains will form in a sample until the energy cost of
forming a domain wall exceeds the reduction in free energy gained from forming
another domain. Domain walls are the transition region between domains, in which
the local moments are not parallel but the direction of magnetization changes
smoothly from one domain to another. The width of a domain wall is given by the
relation [7];

 2J 
  S  
 Ka 

1/ 2

………………………………………………………………………(1.1)

Where δ is width of domain wall, J is exchange integral, K is anisotropy constant, a
is lattice spacing and S is the magnitude of spin. Equation (1.1) implies thatlarger
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exchange interactions lead to wider domain walls, and larger magnetocrystalline
energies lead to narrower domain walls.
When a ferromagnetic material containing a number of magnetic domains is
magnetized with an external magnetic field, it will not relax back to zero
magnetization after this external field is removed. The magnetization must be
driven back to zero by applying a field in the opposite direction. If an alternating
magnetic field is applied to the material, its magnetization will trace out a closed
loop called a hysteresis loop. This irreversibility in the magnetization is called

hysteresis and it is related to the existence of magnetic domains in the material
that can be realigned in an external field. Once the magnetic domains are
reoriented, it takes some external field cause a second reorientation. In a hysteresis
curve (figure 1.2), the saturation magnetization (M s) is the maximum magnetic
moment per unit volume. The coercivity (Hc) is the magnitude of the magnetic field
required to return the magnetization zero after
Ms being driven to saturation. The
M

Mr

residual magnetization after removing magnetic field on it is called remanent
Hc

magnetization or remanence (Mr) [8].

H

When the size of ferromagnetic material is decreased, a critical is size is reached,
below which it is energetically unfavourable to form a domain boundary. Below this
critical size, the ferromagnet exists only as single domain particles. This critical size
can be estimated from the balance between the magnetostatic energy and energy to
form a domain wall, which is given by [9]:
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dc = [9(AK1 )1/2] /[2Ms2] …………………….(1.1)
Here, A is the exchange constant (which is also referred to as the stiffness constant
or Bloch wall coefficient), K is the magnetocrystalline anisotropy constant, and M s is
the saturation magnetization.

Figure 1.2: Hysteresis loop with Ms, Mr and Hc .
The value of the critical diameter is normally less than 100 nm. For example,
magnetite has dc ~ 80 nm and iron has dc ~ 12 nm [10]. Thus, magnetic
nanoparticles having a diameter on the order of a few nanometers have only a
single magnetic domain. Since the individual spins in the nanoparticles are ordered
ferromagnetically, they rotate coherently, leading to a single large effective
moment.
Because of their crystal structures, magnetic nanoparticles have uniaxial
anisotropy (or cubic anisotropy) and the magnetic moments are typically aligned
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along one direction of the easy axis (or axes). The easy axis refers to the
energetically favorable direction of magnetization in magnetic materials, which is
determined by the crystal lattice and the interaction energies. At zero field, the
actual direction of the magnetization will normally be point along one of the two
directions defined by the easy axis. To change the direction of the magnetization,
one has to overcome an energy barrier that is determined by the uniaxial anisotropy
energy together with the external magnetic field. The energy barrier „E A‟ in the
presence of external magnetic field H is given by [5]
EA = V( Ksin2-MHcos) …………………(1.2)
Where V is the volume of the nanoparticle,  is the angle between magnetization
and the easy axis, and  is the angle between external magnetic field and
magnetization as shown in Fig 1.3 a. In the absence of an external magnetic field,
the maximum value of energy barrier is KV and a minima occurs along either of the
easy axis directions (figure 1.3 b).

(a)

(b)

Figure 1.3: (a) Direction of easy axis, magnetization and external field in a magnetic
nanoparticle (b) Energy barrier between two easy axis in a magnetic nanoparticle.
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If the thermal energy KBT is large compared to the value of the energy barrier, the
direction of the nanoparticle moment can flip freely between the two directions
defined by the easy axis. This leads to the moments being randomly oriented, while
fluctuating, so the net magnetization is zero. This phenomenon of showing
paramagnetic

behavior

in

the

magnetically

ordered

phase

is

called

superparamagnetism. The flipping frequency of the nanoparticle moments is given
by the relation:
f = f0 exp(-EA/KBT) …………………(1.3)
Where f0 is the attempt frequency to overcome the energy barrier (E A), having a
value of ~ 1010 Hz. The relaxation time (), which is the average time it takes the
system to jump from one minimum to the other, is the reciprocal of the flipping
frequency (f). Typically, experimental measuring frequency is about 100 sec and at
sufficiently high temperatures, f of nanoparticle moments is higher than the
experimental measuring frequency because of the large thermal energy [4]. At high
temperatures, no hysteresis is observed in the M-H curve, which shows
superparamagnetic behaviour (figure 1.4). As the temperature is lowered, the
flipping frequency (f) decreases, and a critical temperature is reached below which f
becomes smaller than experimental measuring frequency. Below this temperature,
the nanoparticles moments are frozen (on average), and the system shows a
hysteresis loop in the M-H curve conistent with typical ferromagnetic behaviour.
This critical temperature is called blocking temperature TB.

M

8

H
Figure 1.4: Single valued M-H curve of magnetic nanoparticles above their blocking
temperature.
When a system of magnetic nanoparticles is cooled in a zero external
magnetic field and the magnetization is measured on warming in a small applied
field, the zero field cooled (ZFC) magnetization curve is obtained as shown in figure
1.5.

FC
ZFC

M

0

T

Figure 1.5: Typical ZFC and FC magnetization curves.
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Starting from high temperatures, the magnetic moments of individual nanoparticles
are randomly oriented because of thermal energy. When the system is cooled at zero
fields, these moments are frozen in random direction blocking further reorientation
below a certain temperature. This temperature is called the blocking temperature
(TB.). The peak of the ZFC curve corresponds to the blocking temperature. Since
magnetic moments are frozen in random directions, the net magnetization is zero at
sufficiently low temperatures in this ZFC curve. As temperature is increased, the
moments begin to fluctuate because of increasing thermal energy, and these
fluctuating moments tend to align in the direction of the external magnetic field.
Above the blocking temperature the increasing thermal fluctuations tend to
randomize the direction of the individual moments, so the magnetization decreases,
as one observes for a conventional paramagnet. Note that the blocking temperature
depends weakly on applied magnetic field, as can be inferred from Eq. (1.2).
The magnetization curve obtained by cooling a collection of magnetic
nanoparticles in an applied field and then measuring the magnetization on
warming in the same field is called the field cooled (FC) curve, as shown in Figure
1.5. In FC samples, the magnetic moment of each nanoparticle is approximately
frozen along the applied field at low temperatures. The FC curve in Fig. 1.5 shows
a small upturn at the lowest temperatures because of a small paramagnetic
contribution to the signal. As the temperature increases, the alignment of the
magnetic moments decreases as the thermal energy exceeds the anisotropy energy.
Above the blocking temperature, the thermal energy is sufficient to overcome the
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magnetocrystalline energy of nanoparticles. This is why both FC and ZFC curves
show paramagnetic behavior (M  1/T) above the blocking temperature.

1.3

BIOMEDICAL

APPLICATIONS

OF

MAGNETIC

NANOPARTICLES
Magnetic nanoparticles have great potential for applications in medicine.
Some of the specific physical and chemical properties of magnetic nanoparticles that
make them suitable for biomedical applications are: 1) they can be manipulated by
non-invasive external magnetic field 2) they are superparamagnetic with no
remnant magnetization 3) their surface can be easily modified to attach various
molecules and surfactants 4) they are small enough to accumulate inside the living
cells 5) they can be heated by applying an alternating magnetic field 6) they act as
magnetic resonance imaging contrast agents and 7) iron oxide magnetic
nanoparticles are biocompatible with FDA approval for use in vivo. With this
background, magnetic nanoparticles have been used for many

biomedical

applications including magnetically targeted drug delivery, magnetic hyperthermia,
radiation therapy, and as a contrast agent in magnetic resonance imaging (MRI).

1.3.1

DRUG DELIVERY BASED ON MAGNETIC NANOPARTICLES
In 1960, Freeman and collaborators pioneered the concept of magnetically

guided drug delivery using iron nanoparticles [11]. Since this time, the idea of using
magnetic nanoparticles to improve techniques for drug delivery has attracted
tremendous interest. In conventional treatments, the drug is administered through
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intravenous injection and then travels through the heart to be pumped all over the
body [12]. As drugs are normally intended for only a small region in the body (for
example, a cancerous tumor), this standard method for delivery is inefficient as it
requires a larger amount of the drug and may lead to side effects on healthy
systems. In order to overcome these problems, magnetically targeted drug delivery
system (MTDDS) may be used to both limit the amount of drug used and deliver it
to a more precisely controlled region. In MTDDS, biocompatible magnetic
nanoparticles attached with drugs are injected into the blood stream, where they
can be concentrated at specific locations in the body by an external magnetic field
gradient at the targeted area. The drug is then released at the targeted region by
some mechanism, such as changing the pH value, enzymatic action, or increasing
temperature [13].
Magnetite (Fe3O4) and Maghemite (-Fe2O3 ) are the most commonly used
magnetic nanoparticles for targeted drug delivery. These nanoparticles respond well
to external magnetic fields because of their relatively large magnetization.
Additionally, iron oxide is biocompatible and non-toxic. The force acting on a
spherical magnetic nanoparticles in a magnetic field gradient is given by [14, 15]:
F = (m. )B = ½( V/ µ0) B2………………….(1.4)
Where m is the magnetic moment,  is the susceptibility and V is the volume of the
magnetic nanoparticle. B is the external magnetic field acting on the system. At the
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same time, the viscous force arising from the carrier liquid, which acts to oppose
motion produced by the magnetic force, is given by stokes‟ law,
Fvisc = 3dv…………………..(1.5)
where d and v are the diameter and instantaneous velocity of the nanoparticle
respectively, and  is the viscosity of suspending medium. Considering the one
dimensional case, at steady state, the magnetic force and viscous force are equal
which gives the velocity of nanoparticle v,
v = (d2/36 µ0)B 2 …………… (1.6)
For example, taking typical values for the parameters involved in equation (1.6)
including a magnetic field ~ 1T, velocity of magnetic nanoparticles of ~ 10 cm sec -1,
the viscosity of blood ~ 0.0028 Pa-sec, the susceptibility of magnetite ~ 650 and the
diameter of magnetic nanoparticle ~ 10 nm , the magnetic field gradient required
for controlling the motion of nanoparticles in vivo is approximately ~ 9.7 x 10 4 T m-1.

1.3.2

MAGNETIC HYPERTHERMIA
Hyperthermia has the potential to be used for the treatment of malignant

cancer cells. Blood flow is reduced in cancer cells, which makes them more acidic
due to the formation of lactic acid [16]. These acidic tumor cells are temperature
sensitive and are easily killed as the temperature is increased. Furthermore, the
reduced blood flow to tumor cells limits their ability to dissipate heat. As a result,
cancer cells can be eliminated by raising the local temperature between 41 0C to
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450C at the site of tumor [17]. One of the problems associated with hyperthermia is
the fact that healthy cells will generally also be killed if the temperature is
increased significantly.
Different approaches for inducing hyperthermia have been developed,
including: radio-frequency hyperthermia, microwave hyperthermia, whole -body
hyperthermia and in vivo hyperthermia. Of these approaches, in vivo hyperthermia,
in which magnetic nanoparticles are used as a hyperthermic agent, is of particular
interest as these nanoparticles can be injected directly into a blood vessel and
transported to the tumor site by an external magnetic field. Moreover, this localized
hyperthermia is less likely to damage nearby healthy cells because tumor cells can
be heated directly using embedded magnetic nanoparticles and there is a possibility
of differentiating between tumor cells and healthy cells by using an antibodyantigen biological reaction. Magnetic nanoparticles generate heat in an alternating
magnetic field through two relaxation mechanisms: (a) Brownian relaxation and (b)
Néel relaxation. In Brownian relaxation, the whole particle rotates to align with the
applied field and heat is generated because of the friction between particle and the
suspending medium. The heat generation is characterized by a time constant B
B = (3VB)/KBT ……………………..(1.7)
Where V B is the hydrodynamic volume (the total volume of the nanoparticle and
coating in solution) and  is the viscosity of suspending medium. In Néel relaxation,
the magnetic moment rotates away from the easy axis towards the external
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magnetic field without any physical motion of the nanoparticle. In this case, the
heat is produced by the internal magnetic viscosity opposing the change in
magnetization. This heat generation is characterized by a time constant N ,
N = 0 exp(E/KBT) …………………..(1.8)
Where E = KV, K is anisotropy constant and V is the volume of magnetic
nanoparticle. The resultant power generation by the AC magnetic field is given by
[14]:
P = µ00H02 f (2f) /[(1+(2f)2] …………(1.9)
Where f and H0 are the frequency and amplitude of applied alternating magnetic
field respectively, µ0 is permeability of free space, 0 is the magnetic susceptibility
and  is effective time constant which is given by
 = (NB)/(N + B) …………………………….(1.10)
The different mechanisms associated with Néel and Brownian relaxation are shown
in Figure 1.6 [14]. The heat produced from magnetic nanoparticles is usually
referred in terms of specific (power) absorption rate (SAR). This quantity has units
of Wg-1. Mathematically, SAR is given by [18],
SAR = cΔT/Δt …………………………………….. (1.11)
where c is sample specific heat capacity (calculated as mass-weighted mean value of
magnetic carriers and equivalent medium) and ΔT is increase in temperature in the
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Figure 1.6: (a) Magnetic moment (dotted arrow) locked with crystal easy axis (solid
arrow) rotates away from the easy axis towards the magnetic field. (b) The whole
particle with magnetic moment locked with crystal easy axis moves toward
magnetic field. Taken from reference [14].
time interval Δt. Since specific absorption also depends on applied field (H) and
frequency (f), to compare the result with other experiment, SAR can be made
independent of these quantities by dividing with the product of square of the
applied field and frequency and the quantity is referred as intrinsic loss power (ILP)
[19]. So, intrinsic loss power is given by,

ILP 

1.3.3

SAR
………………………………………………………………………(1.12)
H2f

MAGNETIC RESONANCE IMAGING
Magnetic resonance imaging (MRI) is one of the most powerful clinically used

non-invasive imaging techniques, which is based on the principle that protons
precess around the applied magnetic field, B, at the Larmor frequency given by;
w = γB ………………………………………………………………….. (1.13)
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Here γ is the gyromagnetic ratio, having a value of 42.58 MHz/T for protons in
water. A radiofrequency pulse is used to tip the precessing protons and they return
to the original state through two relaxation mechanisms, namely, longitudinal
relaxation, T 1, and transverse relaxation, T 2. T1 and T2 are also called spin-lattice
relaxation and spin-spin relaxation time respectively. Since these relaxation times
are sensitive to the local spin environment, they are used to generate bright and
dark MR images.
Contrast agents are regularly used to enhance the image contrast between
healthy and diseased tissue. Dipolar relaxivity ,R 1,2, the efficiency of a contrast
agent that affects proton relaxation rate, is defined by [20]

R1,2  R10,2  r1,2.C …………………………………………………….(1.14)
Where R 1,2 = 1/T1,2 is the proton relaxation rate in the presence of contrast agent
and R10, 2 is the relaxation rate in the absence of contrast agent . The suffix 1 and 2
correspond to the T 1 and T2 relaxation times respectively. C is the concentration of
the contrast agent and r1,2 is the relaxivity, which measures the increase in
relaxation rate per unit concentration of contrast agent. According to equation
(1.14), the relaxation rate increases with an increase in concentration of the
contrast agent. This allows one to correlate the observed MR signal with the
concentration of contrast agents in tissue. The dipolar interaction between iron
oxide nanoparticles and water proton increases the T 2 relaxation rate, which
decreases the MR signal intensity producing a negative (dark) image. Iron oxide
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also enhances T 2 relaxation rate because of the susceptibility effect. Susceptibility is
the ratio of magnetization (M) of the substance in the presence of external magnetic
field (H):



M
…………………………………………………(1.15)
H

In the susceptibility effect, a magnetization difference due to the inhomogeneous
distribution of magnetic nanoparticles in vivo produces a magnetic field gradient,
which enhances the loss of phase coherence of the spins producing a dark image. In
dipolar interaction, only nearby water protons interact with the nanoparticles while
in the susceptibility effect, proton relaxation is affected far from the magnetic
center. This makes the susceptibility effect an important mechanism to reduce T2
relaxation time in vivo [20]. Iron oxide nanoparticles have an order of magnitude
larger T2-relaxivity than the gadolinium chelates currently being used for clinical
applications. Iron oxide nanoparticles are also a good intravascular contrast ag ent
since they do not leak into interstitium, unlike gadolinium chelates. Paramagnetic
materials having an unpaired electron, such as gadolinium, reduces T 1 and give
high intensity signal producing a positive (bright) image.

1.3.4

RADIATION THERAPY
Radiation can interact with, and damage, cells. While radiation produces

ionization, there are two separate mechanisms through which radiation damages
cells; direct and indirect effects. In direct effects, radiation removes the electrons
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shared by base pairs of DNA. If this interaction affects enough DNA molecules, the
chromosome will not be able to replicate properly, which results in the destruction
of these cells. In indirect effects, radiation ionizes the water in cells to produce
positively charged water molecules (H2O+), which in turn gives a hydrogen ion (H+)
and a hydroxyl radical (OH*). The electron produced by the ionization of water
reacts with another water molecule to give negatively charged water molecule
(H2O-), which further decomposes to give a hydroxyl ion (OH-) and a hydrogen
radical (H*). This hydroxyl radical may react with a hydrogen radical to form a
water molecule. However, since the hydroxyl radical is very reactive, it may also
react with another hydroxyl radical forming hydrogen peroxide (H2O2). This
hydrogen peroxide is toxic and destroys the cells. Energy required for the ionization
of water is 1018 kJ/mole [21] and the absorption cross-section for 500 keV photon in
water is 0.1 cm2/g. The reaction induced in the indirect effect is as follows [22]:
H2O

H2O+ + e-

H2O+

H+ + OH*

e- + H2 O
H2O-

H2OH* + OH-

H* + H*

H2

H+ + OH-

H2O

OH* + OH*

H2O2
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The effects of radiation therapy can be localized using biocompatible metal or
metal oxide nanoparticles, such as gold and iron oxide. When relatively higher
energy radiation is incident on these nanoparticles, ideally accumulated inside
tumor cells, they produce lower energy X-rays and auger electrons with higher
linear energy transfer. Linear energy transfer (LET) is defined as energy lost per
unit path traveled by particles or radiation:

LET 

dE
dx

……………………………………………………………….(1.16)

Since these secondary X-rays and electrons have lower energy and higher
absorption cross-sections, they will not travel as far as higher energy photons to
damage the surrounding healthy cells.
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CHAPTER 2
SYNTHESIS AND CHARACTERIZATION
TECHNIQUES
2.1 SYNTHESIS
Because of the vast potential applications of magnetic nanoparticles,
particularly iron oxide nanoparticles, in medicine, a number of different techniques
have been developed to synthesize γ-Fe2O3 and Fe3O4 nanoparticles in a range of
sizes and shapes. Modifying the Massart method of co-precipitation [23] by varying
the temperature and reaction time, iron oxide nanoparticles of sizes between 4 to 10
nm can be prepared [24]. The arrested precipitation method, where a molecule
added into the salt mixture acts as a growth inhibitor, is also used to synthesize
nanoparticles of smaller sizes [25]. Reverse microemulsion is also used to obtain
iron oxide nanoparticles of size less than 10 nm [26]. For high crytallinity and
narrow size distribution, thermal decomposition of organometallic compounds is
often a suitable synthesis technique [27]. As a single step preparation, laser and
spray pyrolysis of vapour and aerosols have been also reported as a path for
synthesizing nanoparticles [28,29]. Varying the precursor, surfactants and solvents,
the high temperature decomposition method allows the production of nanoparticles
in the range of 10 to 30 nm. Particles with diameters greater than 30 nm can be also
synthesized by co-precipitation while controlling the ratio of ferrous and ferric salts,
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and hexanediamine as a base instead of ammonium hydroxide [30]. Particles having
sizes up to 300 nm can be also obtained by using the oxidizing agent KNO 3 in a
mixture of water/ethanol to oxidize ferrous salt [31,32]. Using different solvents,
changing the nature and concentration of precursors, and adding impurities during
the synthesis can lead to particles having different shapes such as spherical, cubic,
triangular, tetrahedral, and diamond [29]. However, among these many techniques
for synthesizing iron oxide, we use co-precipitation because of its simplicity, and
capacity to produce superparamagnetic iron oxide nanoparticles of reasonable size.
Moreover, the co-precipitation technique is compatible with different approaches for
functionalizing the nanoparticles with organic surfactants. We describe the coprecipitation technique in detail in the following.

2.1.1

SYNTHESIS OF Fe3O4 NANOPARTICLES
We synthesized iron oxide nanoparticles by co-precipitation. This is simple

and efficient technique that was carried out under a fume hood at ambient
conditions. FeCl2.4H2O and FeCl3.6H2O were mixed in a 1:2 molar ratio to ensure
proper stoichiometry and the Fe3O4 nanoparticles were precipitated from solution
by the addition of NH4OH. For a typical synthesis, 10.811 g of FeCl3.6H2O in 40 mL
of 2 M HCl was mixed with 3.976 g of FeCl 2.4H2O in 10 mL of 2 M HCl in a 1 L
beaker. After stirring the mixture with magnetic stirrer for about 5 min, 500 mL of
1 M NH4OH was added dropwise. Initially, the solution turned brown but
eventually changed to black with the formation of Fe 3O4 nanoparticles. The
resultant iron oxide nanoparticles were washed several times with de -ionized (DI)
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water until the supernatant becomes neutral, which was confirmed by litmus paper.
Then, in many cases, a portion of the ferrofluid sample was lyophilized to produce a
powder, which is desirable for many applications. This involved freezing ferrofluid
and keeping the frozen ferrofluid under very low vacuum such that ice directly
convert into water vapor, which is referred to as sublimation. Since drying ferrofluid
at higher temperature may change some properties of iron oxide and coating,
lyophilizing ferrofluid has the advantage of preserving those properties. These iron
oxide nanoparticle obtained from the co-precipitation method has particle diameters
in the range of 10-12 nm. The chemical reaction can be represented by the following
[33]:
FeCl2 + 2FeCl3 + 8NH4OH → Fe3 O4 + 8NH4Cl + 4H2O

(2.1)

Iron oxides form agglomeration unless they are coated with some surfactants. Since
we want to use iron oxide nanoparticles for biomedical application, we have used a
number of different biocompatible surfactants to coat the iron oxide nanoparticles.

2.1.2

FATTY ACIDS COATED IRON OXIDE
Smaller diameter nanoparticles stay longer in the blood stream and have

greater accumulation in the lymph nodes, which is crucial for the diagnosis of
lymph nodes affected by metastases [34]. Since fatty acids have short chain length,
their coating on magnetic nanoparticles makes overall hydrodynamic diameter
smaller as compared long chain length polymer, which make fatty acid coated
nanoparticles useful for the diagnosis of disease. In order to coat the nanoparticles
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with myristic acid (MA), 2 g of the Fe 3O4 was mixed with 2 g of myristic acid
dissolved in 50 mL of acetone. This mixture was stirred for 30 minutes, rinsed with
methanol and then dispersed in cyclohexane to make ferrofluid of myristic acid
coated Fe3O4 (MA-Fe3O4 ). Since fatty acid doesn‟t dissolve in water we couldn‟t
suspend fatty acid coated nanoparticles in aqueous solution. We used the same
approach to coat the nanoparticles with lauric acid (LA). To coat with oleic acid
(OA), we added 0.4 g of oleic acid into 275 ml of iron oxide solution synthesized in
section 2.1.1 before rinsing. The solution contains about 2 g of iron oxide. The
mixture was continuously stirred with a magnetic stir rod and boiled for half an
hour at a temperature of 85 oC. The mixture was then rinsed several times until the
litmus paper shows pH of the supernatant neutral. OA coated Fe 3O4 (OA-Fe3O4)
was also dispersed in cyclohexane to make ferrofluid. We expect that while myristic
acid and lauric acid coated nanoparticles may be useful for some applications, the
high temperature preparation required for oleic acid coating may be incompatible
with a number of biologically relevant molecules.

2.1.3

DEXTRAN COATED IRON OXIDE
Dextran is biocompatible and its coating on iron oxide nanoparticles makes

these nanoparticles long circulating without recognized by immune system of body,
which makes dextran coated iron oxide nanoparticle a good contrast agent for
magnetic resonance imaging. In addition, dextran is easy to functionalize and label
with some optically, biologically, and therapeutically relevant molecules. In order to
coat the iron oxide nanoparticles with dextran surfactant, 2 g of magnetite
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nanoparticles were dispersed in 25 ml of 0.5 M NaOH and 2 g of 15-20 kDa dextran
(or other molecular weight dextran) was dispersed in a separate 25 ml of 0.5 M
NaOH solution. The iron oxide solution was added dropwise to the dextran solution
under sonication for half an hour and the resulting mixture was left under
sonication for 24 h. Dextran coated iron oxide are not stable in water. However,
they are stable in 0.5 M NaOH and cell growth medium.

2.1.4

FUNCTIONALIZING IRON OXIDE TO ATTACH FITC AND

TAT PEPTIDE
In many cases, it is desirable to introduce new properties to the magnetic
nanoparticles by attaching different functional groups.

Fluoro isothiocyanate

(FITC) is a widely used fluorescent dye, frequently used for imaging in confocal
microscopy [35], and tat peptide has been shown to selectively target the cell
nucleus [35]. To add FITC and tat peptide to dextran coated nanoparticles, 0.5 ml of
Dextran coated Fe3O4 nanoparticles were added to a solution containing 2.5 ml of 5
M NaOH, 1 ml of DI water and 1 ml of epichlorohydrin[36]. The mixture was
incubated at room temperature for 24 h with shaking to promote the interaction
between organic phase of epichlorohydrin and aqueous phase of dextran Fe 3O4
colloid. After 24 hr of incubation, the mixture was dialyzed several times using 10
kDa cut off filters to remove the excess of epichlorohydrin. Subsequently, 1.25 ml of
concentrated ammonium hydroxide was added and the mixture was left for
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sonication overnight [35]. The resulting solution is amino functionalized dextran
Fe3O4.
To label dextran coated Fe3O4 with FITC, 1 ml of 0.01 M FITC (10 μmol) in
phosphate buffer saline (PBS) with pH 7.4 was added to 1 ml of amino
functionalized dextran Fe3O4 [37]. The mixture was allowed to stand for 1 hr at
room temperature. Excess FITC was then removed by dialysis using using 10 kDa
cut off filters.
To attach tat peptide to the FITC labeled dextran Fe 3O4, we added 90 μL of
tat peptide solution in PBS (803 μM) to 110 μL of Fe3O4 -Dex-NH2 -FITC and the
mixture was allowed to react overnight at room temperature. We also tried to
attach tat peptide using the heterobifunctional crosslinker N-succinimidyl 3-(2pyridyldithio) propionate (SPDP) [32]. 50 μL of N -succinimidyl 3-(2-pyridyldithio)
propionate (SPDP, 25 mM) in dimethyl sulfoxide (DMSO) was added to 60 μL of
Fe3O4-Dex-NH2-FITC and the mixture was allowed to stand for 1 hr at room
temperature. 90 μL of tat peptide solution in PBS (803 μM) was then added to the
mixture of SPDP and Fe3O4-Dex-NH2-FITC and the mixture was allowed to react
overnight at room temperature. However, since the tat peptide did not have a thiol
group (sulfhydride), the crosslinker did not attach the tat peptide. We also
attempted to attach tat peptide to amine functionalized dextran Fe 3O4 without
FITC. 50 μL of N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP, 25 mM) in
DMSO was added to 60 μL of Fe3O4-Dex-NH2 in PBS and the mixture was allowed
to stand for 1 hr at room temperature. 90 μL of tat peptide solution in PBS (803 μM)
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was then added to the mixture of SPDP and Fe 3O4-Dex-NH2 and the mixture was
allowed to react overnight at room temperature. In this case as well, the crosslinker
did not attach tat peptide because of the absence of thiol group.

2.1.5

HYALURONIC ACID COATED IRON OXIDE
Hyaluronic acid (HA) is a major component of vertebrate tissue and body

fluid, which has been used to target tumor cells in various nanomedicine studies
[38]. In order to coat the iron oxide nanoparticles with hyaluronic acid, 80 mg of
magnetite nanoparticles were dispersed in 1 ml of 0.5 M NaOH and 80 mg of
hyaluronic acid was dispersed in a separate 1 ml of 0.5 M NaOH solution. The iron
oxide solution was added dropwise to the hyaluronic acid solution, which was
sonicated over a period of 15 minutes, with the resulting mixture being held under
sonication for 24 h.

2.1.6

IRON OXIDE ADSORBED ON PNIPAM
Poly-N-isopropylacrylamide(PNIPAM) is a thermosensitive polymer which

absorbs water and swells below a critical temperature, referred as lower critical
solution temperature (LCST), and shrinks and releases water above LCST. This
property has been used to load and release the drug from these microgels [39].
PNIPAM microgels were synthesized by a free radical polymerization technique
[40]. In this process, 550 mg of N-isopropylacrylamide and 50 mg of N,Nmethylenebis-acrylamide were dissolved in 40 ml of de-ionized water to which 5 ml
of an aqueous solution having 250 mg ammonium persulfate (50 mg/ml) was added
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as an initiator. The mixture was stirred for 15 min under a nitrogen atmosphere at
a constant temperature of 343 K, which was maintained by using hot plate and oil
bath. After 15 min, 5 ml of an aqueous solution with 35 mg sodium acrylate was
added to increase the density of carboxylic groups to promote iron oxide
nanoparticle attachment. The mixture was refluxed (condensing water vapor using
cold water) under the same conditions for 4 h. After this procedure, the microgels
were dialyzed in de-ionized water for two days, freeze dried, and preserved at room
temperature. The microgel sample obtained after adding sodium acrylate on
PNIPAM is designated as PNIPAM-SA.

We mixed 467 mg of magnetite

nanoparticles with 200 mg of PNIPAM-SA for 24 h using a non-magnetic stirrer to
avoid promoting agglomeration. In order to increase the colloidal stability of the
composite, we added 60 mg of sodium poly(styrene-sulfonate) (PSS) to the magnetic
microgels and stirred the resulting mixture for 48 h at room temperature. Finally,
the mixture was centrifuged, and washed several times.

2.1.7

TETRAMETHYLAMMONIUM HYDROXID COATED IRON

OXIDE
Tetramethylammonium hydroxide (TMAH) coating creates negative charge
on the surface of nanoparticles and makes stable ferrofluid. TMAH coating also
facilitate silica coating on these nanoparticles. In addition, it may be also helpful to
disperse TMAH coated iron oxide for the electron transport study where polymer
coating is not needed. 280 mg of iron oxide nanoparticles synthesized in section

28

2.1.1 were dispersed in 10 mL stock solution of tetramethyl ammonium hydroxide
(TMAH). 20 mL of DI water was then added into the mixture, which was agitated
for 10 min to ensure the dispersion and stability of iron oxide nanoparticles.

2.1.8

SYNTHESIS OF Mn3O4 NANOPARTICLES
In addition to the iron oxide nanoparticles used for biomedical studies, we

also prepare Mn3O4 nanoparticles for investigations on magnetodielectric coupling
in nanomaterials. We used a co-precipitation method to synthesize Mn3O4
nanoparticles by mixing 19.8 g of MnCl 2 in 100 mL of HCl and de-ionized water in a
1:9 ratio. We then added 50 mL of NH4 OH drop wise to produce a light brown
precipitate. We rinsed this precipitate a number of times using de-ionized water to
remove any residual ions before filtering the solution and drying the sample in air
for 1 hr at a temperature of 100 0C. The dried precipitate was again heated in air for
1 hr maintaining a temperature of 500 0C, at which time the powder changed to a
dark brown.

2.1.9

EFFECT OF CARRIER LIQUID ON FERROFLUID
Surfactants need to be soluble in the carrier liquid to form a well dispersed

ferrofluid. We had tried to disperse fatty acids (MA, LA and OA) coated iron oxide in
water but the particles settled down since the fatty acids were not soluble in water.
However, these nanoparticles form a stable ferrofluid in cyclohexane because MA,
LA and OA are soluble in cyclohexane. In some cases, even the surfactant is soluble
in the carrier liquid, it is necessary to develop some charge on the surface of
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nanoparticles to ensure good solubility. Dextran is soluble in water so we initially
tried to disperse dextran coated iron oxide nanoparticles in DI water but found that
they settled down quickly. We then dispersed dextran coated iron oxide in 0.5 M
NaOH, which created negative charge on the surface of dextran coated
nanoparticles, and the particles were well dispersed in the solution because of
electrostatic repulsion. Similarly, iron oxide nanoparticles labeled with tat peptide
could be well dispersed in 0.01 M growth medium with pH 7.4 whereas they settled
down in 0.01 M phosphate buffer saline (PBS) with pH 7.4 in few hours.

2.2 CHARACTERIZATION TECHNIQUES
We need to characterize the sample to confirm that we have prepared
materials having the required properties for different applications. We have used
different characterization techniques to study structure, size and composition of the
samples prepared for many biomedical applications, among others. Various
techniques that we used for the characterization are described in the following:

2.2.1

X-RAY DIFFRACTION
X-rays are electromagnetic radiation with the wavelength of 0.01 to 10 nm.

Hard X-rays (short wavelength X-rays) have wavelength comparable to the size of
atoms and can be used to probe the arrangement of atoms and molecules inside the
crystalline materials. Generally, X- rays of wavelength 1.54 Å and 0.8 Å produced
by Cu and Mo targets respectively are used in diffractometers. When X-rays
interact with atoms of the materials, diffracted waves from different layers of atoms
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interfere with one other to produce sharp maxima in the intensity if atoms are
arranged periodically. The X-ray diffraction pattern gives the arrangement of atoms
and structure of the crystalline solid in reciprocal space. Conditions of diffraction is
given by Bragg‟s law [41],
2d sin  n ……………………………………………………………(2.2)

Where d is the spacing between the crystal planes, λ is the wavelength of incident
X-ray beam and n is the order of diffraction. The characteristic length scale for the
crystalline structure „L‟ can be calculated from the diffraction peak width using the
Debye-Scherrer‟s equation [42],

FWHM 

0.9
………………………………………………………….(2.3)
L cos 

Where FWHM is full width half maximum of the diffraction peak and θ is the
diffraction angle. This neglects effects from instrumental broadening, among other
effects,

which

limits

the

size

determination

to

nanoparticles

less

than

approximately 40 nm for the diffractometer used in this study. We used Cu Kα
radiation on a Rigaku Ru2000 rotating anode diffractometer operating at a voltage
of 40 kV and current of 150 mA to collect X-ray diffraction (XRD) patterns of
different powder samples.

2.2.2

TRANSMISSION ELECTRON MICROSCOPY (TEM)
The transmission electron microscope (TEM) operates on the same principles

as that of optical microscope but the TEM uses electrons instead of light. TEM uses
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electrons as the “light source” and their much smaller wavelength make it possible
to get a resolution a thousand times better than with a light microscopes. TEM can
be used to see objects to the order of a few angstrom (10 -10 m). Because of its high
magnifications, TEM has been a valuable tool in medical, biological, and materials
research. A "light source" at the top of the microscope emits the electrons that travel
through vacuum in the column of the microscope. Instead of glass lenses focusing
the light in the light microscope, the TEM uses electromagnetic lenses to focus the
electrons into a very thin beam. The electron beam then travels through the
specimen we want to study. Depending on the density of the material present, some
of the electrons are scattered and disappear from the beam. At the bottom of the
microscope the unscattered electrons hit a fluorescent screen, which gives rise to a
"shadow image" of the specimen with its different parts displayed in varied
darkness according to their density. We used JOEL HR TEM 2010, operated at 200
kV, to image the particles. Ferroflud was diluted using its carrier liquid and a drop
of dilute solution of ferrofluid was put in the copper grid and the sample was dried
before imaging. We note that this process of drying the ferrofluid can lead to some
agglomeration of the nanoparticles, which is then observed in TEM images of the
sample.

2.2.3

SCANNING ELECTRON MICROSCOPY (SEM)
Scanning electron microscopy is an excellent technique for characterizing the

surface morphology of materials. It uses electrons instead of light to form an image.
SEM has a large depth of field, which allows more of a specimen to be in focus at
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one time. SEM has also much higher spatial resolution, so closely spaced specimens
can be magnified to much higher levels of about 300 thousand times. Because the
SEM uses electromagnets rather than glass lenses, it offers more control in the
degree of magnification. A beam of electrons with 25 keV is produced at the top of
the microscope by an electron gun. The electron beam follows a vertical path
through the microscope, which is held under vacuum. The beam travels through
electromagnetic fields and lenses, which focus the beam toward the sample. Once
the beam hits the sample, electrons and X-rays are ejected from the sample.
Detectors collect these X-rays, backscattered electrons, and secondary electrons and
convert them into a signal that is sent to a screen, which produces the final image.
We used a Hitachi S-2400 Scanning Electron Microscope to image the particles. The
sample was prepared by dispersing small amount of loosely spaced particles on top
of the conducting silicon wafer and the particles were lightly coated with gold to
avoid charge accumulation while imaging the particles.

2.2.4

THERMOGRAVIMETRIC ANALYSIS (TGA)
Thermogravimetric (TGA) analysis is used for measuring endotherms,

exotherms, and weight loss on heating or cooling [43]. Thermogravimetric analysis
uses heat to force reactions and physical changes in the material under
investigation. TGA provides a quantitative measurement of the mass change in a
system associated with reactions and thermal degradation. TGA records the change
in mass from dehydration, decomposition, and oxidation of a sample with time and
temperature. Characteristic thermogravimetric curves are measured for specific
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materials and chemical compounds due to unique sequence from physicochemical
reactions occurring over specific temperature ranges and heating rates. These
unique characteristics are related to the molecular structure of the sample. We
typically used 5 to 10 mg of powder sample when running TGA analyses. The TGA
instrument used for the measurement was from Perkin Elmer.

2.2.5

FOURIER TRANSFORM INFRARED SPECTROSCOPY (FTIR)
Fourier transform infrared spectroscopy (FTIR) is used to identify unknown

materials, measure the quality or consistency of a sample, and determine the
amount of component in a mixture. In infrared spectroscopy, IR radiation of
wavelength 25 μm is passed through a sample. A portion of this infrared radiation
is absorbed by the sample with the remainder passing through potassium bromide
(KBr).

The resulting spectrum represents the molecular absorption and

transmission [44]. This makes infrared spectroscopy useful for several types of
analysis, including the identification of specific materials or chemical complexes.
We used approximately 1 mg of powder sample which was mixed with about 10 mg
of KBr powder to make a very thin pellet for infrared spectroscopy.

2.2.6

DYNAMIC LIGHT SCATTERING (DLS)
Dynamic Light Scattering is used to determine the hydrodynamic size of

particles in solution. When a monochromatic beam of light, such as a laser, passes
through a solution, Brownian motion of the particles in solution causes time
dependent fluctuation in the intensity of scattered light. It is possible to determine
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the size distribution for a collection of nanoparticles by finding the diffusion
coefficient using the autocorrelation function. The autocorrelation curve can be fit
using a single exponential function, C(τ)=Aexp(-2Γτ)+B, with Γ= Dq2 [45]. The
diffusion coefficient, D, is related to hydrodynamic size by the relation [46],
D = KBT/3πηd ……………………………………………………(2.4)
Where η is the viscosity of the medium and d is hydrodynamic diameter of the
particle. Dynamic light scattering (DLS) measurements were performed using a 90
Plus particle size analyzer from Brookhaven Instrument Corporation. The system
typically operates at an angle of 90° and uses a laser of wavelength 632.8 nm. We
used solutions with concentrations of about 150 μg/ml for these measurements.

2.2.7

FLUORESCENCE CORRELATION SPECTROSCOPY (FCS)
FCS is minimally invasive technique used to determine the concentration,

chemical reaction rate, and diffusion coefficient of fluorescently labeled molecules
from the fluctuation of fluorescence signal. The concentration of the molecules
should be very low, on the order of nanomolar, so that multiple particles do not
contribute to the measured correlation signal. A fluorescent dye, such as fluoro
isothiocyanate (FITC), rhodamine and alexa fluor, is used to label the particles. The
fluorescence intensity is detected from a microscopic volume of about 10 -15 L defined
by the beam of laser light. The time dependent fluorescence intensity is quantified
in terms of temporal autocorrelation function, which is related to the diffusion
coefficient by the relation [47],
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G ( ) 

G (0)
(1  8D  0 2 )(1  8D z 0 2 )1 / 2
…………………………………………………..(2.5)

with G(0) the autocorrelation at t=0, ω0 is the (half) width in lateral direction, and
z0 is the (half) length in the axial direction of the laser focus. From the diffusion
coefficient, we can calculate the hydrodynamic diameter of the particles using the
relation (2.4).

2.2.8

SUPERCONDUCTING QUANTUM INTERFERENCE DEVICE

(SQUID)
A magnetometer is used to measure magnetization as a function of magnetic
field and temperature, which gives the insight of magnetic properties of materials.
Using a Josephson junction, a superconducting quantum interference device
(SQUID) can measure extremely weak magnetic signals. A Josephson junction is
made up of two superconductors, separated by thin normal layer. A direct current
(DC) SQUID consists of two Josephson junctions in parallel so that electrons
tunneling through the junctions demonstrate quantum interference, dependent
upon the strength of the magnetic field within a loop. Schematic diagram of DC
Josephson effect is shown in Fig 2.1. DC SQUIDs show a large change in response
to even tiny variations in a magnetic field. We used both powder and liquid sample
for the magnetic measurement. We put about 20-30 mg of powder sample into a gel
capsule which is further packed by cotton to avoid any motion of particles inside the
capsule. We keep this capsule inside the drinking straw at fixed distance so that the
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Figure 2.1: Shematic diagram of DC Josephson effect.
sample centers well during the measurement. The gel capsule is also fixed inside
the straw by sewing with nylon thread to avoid any motion during the
measurement. Since liquid dissolves gel capsule, we make epoxy capsule by mixing
stycast 1266 part A and B in 100:28 ratio by weight. After curing the mixture of
epoxy in drinking straw, we cut about 1 cm of epoxy and drill a hole to load the
liquid sample, which is further sealed by epoxy cap to avoid any leakage of
ferrofluid. Loading the epoxy capsule into the straw for the measurement is same as
we do for gel capsule.

2.2.9

PHYISCAL PROPERTY MEASUREMENT SYSTEM (PPMS)
Physical

property

measurement

system

(Quantum

Design)

is

a

multifunctional device which is used for the measurement of specific heat, AC and
DC magnetization, and electric and thermal transport in the temperature range
from 1.8 to 400 K with magnetic fields up to 9 T. The PPMS consists of a cryostat
unit having superconducting magnetic coil. Different sample holders can be
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mounted in the cryostat for different measurements, which can be controlled by
proprietary software. The PPMS can detect AC and DC signal upto 10-8 and 10-5
emu. We used the system for different measurements including AC magnetization,
DC magnetization, specific heat capacity, and temperature and field sweep for
dielectric measurements. We used both liquid and solid samples for various
characterization using PPMS.

2.2.10 RAMAN SPECTROSCOPY
Raman spectroscopy is the technique in which the frequency of incident
photon of monochromatic light changes due the inelastic scattering with local modes
in the sample. Local modes may be both phonons and magnons. Phonons are the
quanta of vibration energy of atoms in crystal lattice whereas magnons are the
excitation of spins wave. In case of an interaction with these local modes, the
reemitted light can have a higher or lower frequency than the incident photon,
which is called the Raman effect [48]. The spectrum for the energy-shifted scattered
light gives the information about the vibrational and rotational transition in the
molecule or phonons in the crystal. In many cases, the scattered light may not have
also any change in frequency (elastic scattering), which is referred as Rayleigh
scattering, which does not give information about the molecule. Raman scattering is
non-invasive technique having very weak effect (10 15 times smaller than Rayleigh
scattering), which has very useful application in studying phase transition in
crystal, investigating defect in crystal, measuring stress, and fingerprinting
molecules. Since the impurities introduced into the crystal change the vibration
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modes of phonons which is detected very well in Raman Spectrocopy and is also
better techniques to detect defects in crystal as compared to XRD. We used solid
samples by making the pellet to collect Raman spectra. Ar+ ion-laser (514.5 nm)
with a Triax 550 detector was used to collect the Raman spectra.
2.2.11 MÖSSBAUER SPECTROSCPY
Mössbauer spectroscopy is a technique that has been used in different area of
Physics, Chemistry, Biology and Metallurgy and is based on the Mössbauer effect.
When atoms are fixed in a crystal lattice, the emission and absorption of gamma
radiation due to the transition in nuclear ground and excited state is recoil free
because of the coupling to the entire mass of the crystal. This allows one to
investigate the hyperfine structure of nuclear energy levels and different valence
state of elements. Source, sample, detector and a drive to move the source or
absorber, are the basic component in the Mössbauer spectroscopy instrument.
Generally, source is moved toward the sample to shift the energy level. For
example, 57Fe source moving toward a sample with a velocity of 1 mm/sec increases
the emitted photon by ten natural linewidths. Mössbauer spectra are described by
the isomer shift (δ), quadrupole splitting (Δ) and hyperfine splitting. The isomer
shift is related to the difference in energy of absorber and source, which arises from
the difference in electron density at the nucleus. Quadrupole splitting is caused by
the interaction between the nuclear quadrupole moment and electric field gradient
produced by nearby electron.

This results the splitting of individual peak into

doublet in the absorption spectrum. The isomer shift moves the resonance
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absorption away from zero velocity while the quadrupole splitting introduces a
separation between the two component peaks of the absorption doublet. Isomer shift
and qudrupole splitting are generally evaluated with respect to reference material.
In magnetic materials, due to the presence of magnetic field at nucleus, hyperfine
splitting occurs and produces sextet pattern, as the hyperfine energy levels depend
on the quantum numbers of the Fe ions. The combination of isomer shift,
quadrupole splitting and hyperfine field is sufficient to provide information about
site occupancy and valence state of Fe atom. Since Mössbauer parameters are
temperature sensitive, measurements at lower temperatures can provide better
peak resolution. We used a solid sample of about 70 mg to obtain the Mössbauer
spectra at 78 and 300 K as described in section 3.3.1.
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CHAPTER 3
PHYSICAL PROPERTIES OF NANOPARTICLES IN
SOLUTION
3.1 INTRODUCTION
Because superparamagnetic iron oxide nanoparticles have potential
technological [49] and biomedical [1] applications, it is of great importance to
understand the static and dynamic magnetic behavior of these nanoparticles
dispersed in carrier liquid. To make iron oxide nanoparticles well dispersed in
solution, the surface of these nanoparticles needs to be sterically stabilized by
coating with a suitable organic or inorganic surfactant. The hydrodynamic size,
which is the size of core and surfactant layer together, plays an important role for
biomedical applications of these nanoparticles. The hydrodynamic size of the coated
nanoparticles is typically determined by estimating the diffusion constant of the
system in solution and then relating this to the particle size through the Stokes
Einstein relation [50]. A number of techniques, including dynamical light scattering
(DLS) and fluorescence correlation spectroscopy (FCS) can be used to determine the
diffusion constant in solution [51,52]. Other approaches can also be used to estimate
the hydrodynamic size, including using magnetic susceptibility to measure the
relaxation time in a particular solvent [53]. All of these techniques consider only
single particle effects, since the threshold concentration for changes in the effective
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viscosity is larger than that typically considered in ferrofluids [54].

This also

assumes that magnetic interactions can be neglected, which is reasonable as dipolar
interactions will be very weak for dilute solutions.
In some previous studies, the hydrodynamic diameter estimated using DLS
significantly exceeds the expected size. A factor of two difference was found between
the hydrodynamic diameter of octadecyltrichlorosilane coated nanoparticles
determined using DLS measurements, approximately 90 nm, and the diameter
estimated from atomic force microscopy studies, 54 nm, with the difference being
attributed at least in part to solvents [55]. In another study, 10 nm magnetite
nanoparticles coated with polydimethylsiloxane were found to have a diameter of 53
nm using DLS, while theoretical calculations based on chain extension predict a
size of 28 nm [56]. These results have important implications for measurements of
particle size, as having accurate particle size information is crucial for determining
the suitability of different polymer coated nanoparticles for specific applications. In
order to address this point, we have measured the hydrodynamic diameter of Fe 3O4
nanoparticles coated with a monolayer of dextran in solution using different
techniques and compared these results together with other estimates for the
particle sizes.
Since the surfactant coating also changes charge, functionality, reactivity of
the nanoparticles, and can enhance the stability and dispersion of nanopaticles in
carrier liquid, it is also important to investigate other effects of surfactant coatings
including magnetohydrodynamic response. Surface coating with dextran [57],
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deoxyribonucleic acid (DNA) [58], yeast alcohol dehydrogenase (YADH) [59],
polyethyleneglyocol (PEG) [60], silica [61], polyvinyl alcohol (PVA) [62], heparin
[63], phospholipids [64] and alkyl phosphonate/phosphate [65] on iron oxide
nanoparticles can improve their biocompatibility for in-vivo applications. Numerous
investigations have been reported on the effects of surface coatings on the magnetic
properties of the nanoparticles. Fu et al [66] found no significant effect on the
coercivity or blocking temperature of Fe 3O4 nanoparticles coated with lauric acid or
decanoic acid. However, for 6 nm Fe3O4 nanoparticles coated with gold [67], the
blocking temperature increased from 80 K to ~130 K when the particles were coated
with methoxypolyethylene glycol (MPEG). The difference

in the blocking

temperature was attributed to the interaction between the iron oxide nanoparticles
and the polymer coating.
The saturation magnetization of Fe 3O4 nanoparticles coated with oleic acid
can exhibit an anomalous temperature dependence, believed to be caused by the
modification of the superexchange interaction between the iron ions from the
surface layer of the nanoparticles in presence of the surfactant [68,69]. There has,
however, been limited work on investigating the effects of the surface coating
thickness on the magnetohydrodynamic and Brownian relaxation mechanism of
magnetic nanoparticles. In one recent study, Vekas et al [70] have examined the
stability of magnetite nanoparticles coated with surfactants of different chain
lengths, such as lauric acid, myristic acid, dodecyclbenzene sulphonic acid, and oleic
acid dispersed in transformer oil and water.

It was found that the oleic acid
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surfactant with 18 carbon atoms and a double bond was more effective in producing
a stable dispersion than the shorter chain length surfactants such as lauric acid (12
carbon atoms) and myristic acid (14 carbon atoms). The thickness of the surfactant
molecules will modify the hydrodynamic radius of the nanoparticles, and is expected
to play an important role in determining the ac magnetic response of the system.
The loss component of the magnetic susceptibility in ferrofluids depends strongly on
both Brownian relaxation, with the entire nanoparticle rotating in the carrier
liquid, and on Néel relaxation, with the magnetic moment of the nanoparticle
reversing direction with no physical rotation of the nanoparticle. These relaxation
mechanisms depend on the size of the magnetic nanoparticles (Néel) or on the
hydrodynamic size of the coated nanoparticles (Brownian).

Additionally, the

magnetohydrodynamic response of ferrofluids to external dc magnetic fields, which
leads to chain formation, depends strongly on both the size of the magnetic
nanoparticle core as well as the overall hydrodynamic size.
Within this framework, preparing nominally identical Fe 3O4 nanoparticles
coated with surfactants having different chain lengths would allow the effects of
Brownian relaxation to be distinguished from the effects of Néel relaxation. The
similar Fe3O4 core size would ensure similar Néel relaxation behavior, while the
Brownian relaxation, which depends on hydrodynamic radius, would lead to a
different ac magnetic response in the nanoparticles. With these motivations in
mind, we studied magnetohydrodynamic response of luaric acid (LA), myristic acid
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(MA) and oleic acid (OA) coated Fe3O4 nanoparticles in the presence of both AC and
DC magnetic field.
Another interesting property of magnetic nanoparticles in solution is that
they produce heat in the presence of alternating magnetic field through Néel and
Brownian relaxation, which is referred as magnetic hyperthermia. While majority of
studies on magnetic nanoparticle hyperthermia have been targeting biomedical
applications [71-74], as heating neoplastic cells to 41-45

oC

can produce the

preferential death of cancer cells, there are a number of other intriguing
possibilities, including magnetically controlled curing of epoxies [75] and the
selective heating of nanoparticles for catalysts in synthesis reactions [76].
Furthermore, the mechanisms expected to contribute to magnetic heating have
well-defined temperature dependences, so it is important to experimentally
investigate temperature dependent magnetic hyperthermia in order to test these
specific models.
The relaxation of nanoparticle magnetic moments in a liquid ferrofluid,
responsible for heat generation in magnetic nanoparticles exposed to ac magnetic
field, occurs through two primary mechanisms; Néel and Brownian relaxation. Both
of these relaxation mechanisms occur concurrently, but independently, in liquid
suspensions of nanoparticles, but only Néel relaxation persists for nanoparticles
embedded in a rigid matrix, including a frozen solid. A number of studies have
explored the Néel and Brownian relaxation mechanisms near room temperature by
studying the magnetic response for nanoparticles samples in liquid and solid
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matrices [77-79]. Typically, the Néel relaxation is investigated by restricting
Brownian relaxation using epoxy, wax, or similar agent to eliminate nanoparticle
motion. While there is considerable interest in understanding the details of
magnetic hyperthermia in nanoparticles, the majority of studies, both theoretical
and experimental, have focused on exploring the dependence of magnetic heating on
particle size [80,81] and frequency [82]. Rosensweig has theoretically investigated
the heating rate as a function of both particle size and viscosity in great detail [80],
while Seehra and coworkers have demonstrated that the magnetic susceptibility of
3 nm and 9 nm FePt nanoparticles, directly affecting the magnetic heating, depends
strongly on particle size [81].

Studies by Lacroix and co-authors on FeCo

nanoparticles on magnetic losses in the frequency range from 2 kHz to 100 kHz
have explored the frequency dependence of the magnetic heating [82].
Our investigations on the temperature dependence of the magnetic heating
complement these earlier studies, and provide an additional check on the
underlying validity of the magnetic relaxation models.

These studies are

particularly relevant given the recent interest in testing the range of validity for the
Néel relaxation model [83]. Our work aims to explore the effects of magnetic
hyperthermia on frozen ferrofluids and to investigate the te mperature dependence
of the Néel, present in both the solid and liquid states, and Brownian, present in
only the liquid state, relaxation mechanisms.
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3.2 DEXTRAN COATED IRON OXIDE NANOPARTICLES
Dextran is a long chain polysaccharide made up of glucose units. The
molecular weight of dextran varies from 1 kDa to 2000 kDa. Dextran is neutral,
easily soluble in water, stable, biocompatible, and biodegradable. It can be
functionalized with many charged groups, such as amine and carboxylic groups to
attach biological entities including drugs, fluorescent dyes, and peptides. Dextran is
used clinically for replacing lost blood, plasma substitution, as a volume expander
in anemia, in solutions for storing organs for transplantation, and as a carrier for
vaccines, among other applications [84]. Dextran is also used as a starting and
intermediate reagent for the wide range of synthesis in biotechnological and
technical industries, including in the photographic industry to improve the quality
of

silver

emulsions

of

photograph.

Because

of

biocompatibility,

ease

of

functionalization, freedom to choose different molecular weight, and wide ranges of
applications, we chose dextran to coat the iron oxide nanoparticles. These dextran
coated nanoparticles were used to determine the hydrodynamic size by different
techniques, such as, dynamic light scattering (DLS), fluorescent correlation
spectroscopy (FCS) and AC magnetization measurements. This allowed us to
investigate which technique of determining hydrodynamic size gives theoretically
expected hydrodynamic size. We also used the dextran coated nanoparticles to
investigate the magnetic heating in both frozen and liquid ferrofluid to investigate
the behavior of magnetic heating with temperature.
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3.2.1

EXPERIMENTAL DETAILS
Dextran coated iron oxide nanoparticles were synthesized as described in

section 2.1.3. We used different chain lengths of dextran, 5 kDa, 15-20 kDa, 60-90
kDa and 670 kDa, to coat the iron oxide nanoparticles and dispersed these dextran
coated iron oxide nanoparticles in 0.5 M NaOH. The crystalline structure and size of
the iron oxide nanoparticles was determined from X-ray diffraction patterns
collected using Cu Kα radiation on a Rigaku Ru2000 rotating anode diffractometer.
Transmission electron microscope (TEM) images were also taken using a JOEL HR
TEM 2010 operating at 200 kV to confirm the core size of the nanoparticles.
Dynamic light scattering on a 90 Plus particle size analyzer from Brookhaven
Instrument Corporation was used to estimate the hydrodynamic size of the
nanoparticles. For the FCS measurement, 15-20 kDa dextran coated iron oxide was
crosslinked

with

epichlorohydrin,

aminated

and

labeled

with

fluorescein

isothiocyanate (FITC) as described in section 2.1.4. For the hyperthermia
measurements, we used the set up shown in Figure 3.1. This hyperthermia
apparatus, shown in figure 3.1, consists of a parallel LC tank circuit, with a
capacitor having a capacitance of 0.02 μF and coil made from 1/8” Cu tubing having
an inductance of 8 μH. Though the current passing into and out of the tank circuit
is small, the current inside the parallel LC circuit is high because of the reactive
current, which is an advantage of this configuration as compared to a simple series
LC circuit. Since the current coming out of the system is small because of the
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cancellation of the reactive current passing in opposite directions through the
inductor and capacitor, it also avoids the use of a high power resistance and larger

Figure 3.1: Magnetic hyperthermia set-up.
heat sink as required for a series LC circuit. Since the magnetic field is directly
proportional to the current flowing through the coil, higher currents gives higher
magnetic fields, which are desirable for most applications.
We used the RF generator model CLX-2750 from COMDEL, which can
deliver a power of 2500 W. We used only 200 W of delivered power, which gave a
current of roughly 18 A through the coil, which was measured using the mutual
inductance to a separate pick-up coil, producing an alternating magnetic field of 70
Oe. If the circuit is not in resonance, the amplifier is unable deliver the required
power because of the impedance mismatch. In order for the tank circuit to be on
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resonance, we had to connect the power supply to the proper tapping point on the
coil, as illustrated in Figure 3.1. The circuit was in resonance at about 395 kHz,
which was the operating frequency for the hyperthermia measurements discussed
in this work. Since a relatively high current was passing through the coil, we used a
small pump to flow water continuously through the copper tubing to provide cooling.
This also served to minimize possible radiative heat transfer from the coil to the
sample. For the hyperthermia measurements on frozen and liquid ferrofluid, we
used 10 ml of ferrofluid in a plastic vial having a diameter and height of about 2
inches. The vial was also insulated with cotton padding and styrofoam to minimize
the heat exchange with environment. We used liquid nitrogen to freeze the sample,
but started measurements only at– 45 o C. The sample was kept inside the coil and
rise in temperature of the ferrofluid in the presence of alternating magnetic field
was measured by IR thermometer from Extech Instruments. This thermometer was
positioned to ensure that the beam area covered the largest possible fraction of the
top surface of the sample, without impinging on the walls of the container. In
practice, this corresponded to a distance of approximately 8.5” above the sample.

3.2.2

RESULTS AND DISSCUSSIONS

The results of the structural and magnetic characterizations on the dextran coated
iron oxide nanoparticles are shown in Fig 3.2. Figs 3.2 a, b, c and d show the X-ray
diffraction patterns, TEM images, thermogravimetric analysis (TGA) curve and the
room temperature magnetization curve of the dextran coated Fe 3O4 nanoparticles
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respectively. From TEM images, diameter of the iron oxide nanoparticles is 12 nm
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Figure 3.2: (a) X-ray diffraction spectrum of freeze dried 15 -20 kDa dextran Fe3O4
(b) TEM images of 15-20 kDa dextran coated Fe3O4 nanoparticls (c)
Thermogravimetric analysis data for the 15 -20 kDa and 60-90 kDa molecular mass
dextran coated nanoparticles and (d) room temperature M(H) curve of 15-20 kDa
dextran dextran coated Fe3O4 ferrofluid.
Thermogravimetric analysis (TGA) on 15-20 kDa and 60-90 kDa dextran coated
samples showed single step sharp drop in weight close to 770 o C and 730 o C
respectively, providing evidence that there is a monolayer coating on these samples
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[85]. Previous reports suggest that two sharp transitions should be seen in TGA for
bilayer polymer coatings [86]. There was a weight loss of 45 % and 50% for the 15 20 kDa and 60 – 90 kDa dextran coated sample respectively, consistent with the
lower molecular mass polymer making a smaller contribution to the total mass of
the composite. We also expect the geometry of these polymer coated nanoparticles
to depend on the molecular mass of the coating. The XRD peaks can be fully indexed
to the Fe3O4 crystal structure, with no evidence for impurity phases. Transmission
electron microscopy images show the core. Since lower molecular weight dextran, up
to approximately 10 kDa, is known to extend linearly in solution while higher
molecular weight dextran is coiled [87], the geometry of lower and higher molecular
weight dextran coated sample are expected to differ. These nanoparticles have
single valued M (H) curves at room temperature and exhibit separation between
ZFC and FC curves with a peak in the FC magnetization curve, showing they are
superparamagnetic. The saturation magnetization of these nanoparticles is about
61 emu/g of Fe3O4. This is smaller than the saturation magnetization for bulk
Fe3O4, 93 emu/g, but consistent with other studies on iron oxide nanoparticles,
which typically show smaller magnetizations than bulk [88].
Since the hydrodynamic size of the nanoparticles is crucial for both magnetic
heating as well as biomedical application, we determined hydrodynamic size of
different chain length dextran coated sample using a number of different
techniques including dynamic light scattering (DLS), AC magnetization, and
fluorescent correlation spectroscopy (FCS). For dynamic light scattering, to give
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enough scattering of light but avoid the agglomeration of nanoparticles, we diluted
the original solution by 1:250, giving a volume fraction of nanoparticles ϕ=0.2% in
the solution.
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Figure 3.3 (a) Autocorrelation curve measured using DLS for 5 kDa dextran coated
sample. The dashed line is the fit to an exponential function having a single
exponent. (b) Imaginary part of the ac magnetic susceptibility as a function of
frequency for the different chain length dextran coated sample. The arrow indicates
the peak in magnetic relaxation associated with Brownian relaxation. (c)
Representative correlation curve measured for a 15-20 kDa dextran coated
nanoparticle measured using FCS. (d) Histogram showing the frequency
distribution of nanoparticle sizes using repeated FCS measurements.
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The DLS system was calibrated before doing the measurement by using polystyrene
beads of know size of about 10 nm suspended in water. This helped to to rule out
any possibility of instrumental error. A representative curve for the 5 kDa dextran
coated sample, with DLS data and fit of single exponential function, C(τ)=Aexp(2Γτ)+B, where Γ=Dq2, is shown in Fig 3.3a. This autocorrelation curve fit, using a
refractive index 1.34 for the 0.5 M NaOH solution [89], gives the diffusion constant
D. From this, we calculated the hydrodynamic diameter of the nanoparticles using
the Stokes-Einstein equation [90]:

D

kBT
3d

………………………………………………………….(3.1)

This considered a viscosity of η=0.96 cp, for the NaOH solution at room



temperature, T=298 K. We found the hydrodynamic diameter of 5 kDa dextran
coated sample to be 91 nm. Similar analysis on higher chain length dextran coated
sample gave sizes up to 132 nm. The DLS sizes for different chain length dextran
coated sample are shown in Fig. 3.4, which also includes the sizes estimated using
different techniques, as discussed in the following. Because the relaxation rate for
particles depends on the hydrodynamic radius, the size of magnetic nanoparticles
can also be indirectly determined from the magnetic loss. For these AC magnetic
susceptibility measurement, we sealed 37 mm3 of as-prepared solution in epoxy
capsules for each of the different chain length dextran coated samples, and
measured the out of phase component of the magnetic response as function of
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frequency at room temperature, using Quantum Design PPMS equipped with the
ACMS option. These curves are shown in Fig 3.3b.
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Figure 3.4. Hydrodynamic size for the dextran coated nanoparticles as determined
using dynamical light scattering
(DLS) and ac magnetic susceptibility
measurements (ACMS) as a function of the molecular weight of dextran. The
fluorescence correlation spectroscopy (FCS) measurement on the single
representative 15-20 kDa dextran coated nanoparticle sample is shown as the open
star for comparison. The solid lines show a decaying exponential fit to the data.
The relaxation peak corresponding to Brownian relaxation, where ωτB=1, is shown
by arrow. Brownian relaxation is related with the hydrodynamic size of the
nanoparticles by following relation:

B 

d3
2kBT

……………………………………………………………(3.2)

Again, using the viscosity of 0.5 M NaOH, η = 0.96, we found a hydrody namic



diameter of 105 nm to 132 nm for 5 kDa to 670 kDa dextran coated sample
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respectively, consistent with the size obtained from DLS measurement. These
values are also potted in Fig 3.4.
As a final check on the hydrodynamic size of the nanoparticles, we did FCS
measurement on the FITC labeled 15-20 kDa dextran coated sample, with volume
fraction of ϕ=0.004%. This is 50 times more dilute than the sample used for DLS
and magnetization measurement. We require such dilute solutions for FCS studies
to ensure that only a single nanoparticles is in the focus of the laser. A
representative curve of autocorrelation function, G() as a function of time () is
shown in Fig. 3.3 (c). We fit these data to the equation [47]:

G ( ) 

G (0)
(1  8D  0 2 )(1  8D z 0 2 )1 / 2

………………………………………..(3.3)

We note that the autocorrelation function is related to the diffusion coefficient D,
which in turn depends on the hydrodynamic size of the nanoparticle. In equation
(3.3), G(0) is the autocorrelation at τ=0, ω0 is the (half) width in lateral direction,
and z0 is the (half) length in the axial direction of the laser focus. We estimated ω 0 
0.45 m and z0  2 m by a calibration experiment using the well-studied dye
rhodamine 6G, whose diffusion coefficient is known to be 280x10-12 m2/s in water.
From our fit, D, is 7.7 μm2/s for the 15-20 kDa dextran coated nanoparticles and we
calculated hydrodynamic diameter this sample to be 57 nm using equation (3.1). We
also repeated the measurement several times and have plotted the statistical
distribution of size of nanoparticles as a histogram in Fig 3.3 (d). This size
distribution implies majority of the size of 15-20 kDa dextran coated sample lies
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within the range of 55 ± 5 nm. The size from FCS measurement is also plotted in
Fig 3.4 along with size from DLS and magnetic measurements.
The size from DLS and magnetic measurement as a function of molecular
weight can be fit to the decaying exponential, y = A[exp(-x/B)]+C, shown by solid
line in Fig 3.4. Studies on pure dextran in solution show the diameter of the coiled
polymer increases rapidly with molecular mass to 10 kDa then increases more
slowly with a further increase in molecular weight [87]. Thus, this shallow increase
in hydrodynamic size for nanoparticles samples coated with higher molecular mass
dextran is consistent with results on pure dextran. However, while the
hydrodynamic

size

determined

using

DLS

and

magnetic

measurements

approximately follow the functional form expected for dextran, the magnitude of
hydrodynamic diameter differs greatly from what is expected based on physical
considerations. Since the chain length of 5 kDa dextran in solution is 18 nm [87],
the hydrodynamic diameter of iron oxide nanoparticles of core diameter 12 nm
coated with a monolayer of 5 kDa dextran should be 48 nm. This is a factor of two
smaller than the size obtained from DLS and magnetic measurement, and well
outside the expected uncertainties for these characterization techniques. Similarly,
the diameter of 20 kDa dextran in solution is 22 nm [87], so the size of the12 nm
iron oxide nanoparticle coated with a monolayer 15-20 kDa molecular mass dextran
should be approximately 56 nm, again about a factor of two smaller than measured
using DLS.
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We find, however, much better agreement between the hydrodynamic size
measured using FCS and the size expected from such physical considerations. The
diameter for the 15-20 kDa coated nanoparticles is approximately 55 +/- 5 nm,
which is completely consistent with the expected size of 56 nm found by combining
the independently measured sizes for the iron oxide nanoparticles and dextran in
solution. Since the DLS unit was properly calibrated before the measurement, and
the results are consistent with the independent magnetic measurements, we believe
that the anomalously large size obtained from DLS not due to any instrumental
error. Furthermore, the discrepancy is not due to the well-known dependence of
viscosity on volume fraction [91] since for a factor of two error in size, the volume
fraction should be two orders of magnitude greater than that we used (ϕ=0.2%) for
these DLS measurement. Similar discrepancies in size have been also observed in
previous studies using DLS to size polymer coated nanoparticles in solution,
although the origin of this difference has not been discussed [55,56]. Considering
our results, we suggest that for polymer coated iron oxide nanoparticles samples,
FCS yields the accurate hydrodynamic size while DLS may overestimate the size by
the factor of two.
We did magnetic hyperthermia measurement on a ferrofluid with 15-20 kDa
dextran coated iron oxide. The ferrofluid was heated in the presence of an
alternating magnetic field of 70 Oe from -45 to 45 o C in 2000 s and the rise in
temperature was measured as a function of time, which is plotted in Fig 3.5a.
Plateau feature seen in the Fig 3.5a is associated with the melting of frozen
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ferrofluid. Rise in temperature of ferrofluid was affected by both ambient and
magnetic heating. We also measured the rise in temperature of the ferrofluid as a
function of time without applying magnetic field, which is plotted in Fig 3.5b in
different time scale along with the result of Fig 3.5a for comparison. Time taken by
ferrofluid at the melting phase due to ambient heating alone is about six times
larger as compared to that the time taken due to ambient and magnetic heating. We
also let the ferrofluid cool under ambient condition after heating it magnetically
from room temperature to 40 o C to estimate the contribution of ambient heat loss in
it. This is shown in Inset of Fig 3.5b. The temperature of ferrofluid as a function of
time in the absence of magnetic field allows us to calculate the ambient heat
exchange with ferrofluid.

Figure 3.5: Temperature versus time for the ferrofluid heated magnetically from -45
to 45 oC (dark curve) and due to ambient heating from -45 oC to room temperature
(gray curve). (a) with magnetic field (b) with and without a magnetic field. Inset:
Thermal relaxation in a ferrofluid heated to +45 o C and allowed to cool to room
temperature in zero applied magnetic field.
We first calculated the ambient heat transfer on frozen ferrofluid assuming
that the heat transfer is radiative rather than ambient. We also assumed that the
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temperature is uniform throughout the sample. The heating equation for the
sample is given by:

dT
 M C  ATR4  T 4   0 ,
dt
…………………………………………………………..(3.4)
Here M, C and T are the mass, specific heat and temperature of the frozen sample,
respectively. The Second term in equation (3.4) represents the radiative heat
transfer from room temperature (TR) to the sample.  is the Stefan-Boltzmann
constant, A is the total area of the sample surface (4x10-3 m2) and  is the
emissivity, which is equatl to 0.98. We solved the equation (3.4) and obtained the
transcendental equation for T as:
3
1 TR T 
1 TR Ti 
1 T 
1 Ti  2TR A








ln
 t an    l n
  t an  T   MC t ,
2  TR T 
TR  2  TR Ti 
 R
…………………… (3.5)

Where Ti is the temperature of the sample at t = 0. We fitted this equation to the
ambient heating data of Fig 3.5b by taking T i = 228 K, T R = 295 K and specific heat
capacity ice as a function of temperature. The fit (solid line) with data is shown in
Fig 3.6a. Since the fit agrees with experimental data, it implies that there is
radiative heat transfer in frozen ferrofluid. We calculated the magnetic heating
power by subtracting ambient heating power in frozen ferrofluid obtained from Fig
3.6 a and plotted as a function of temperature in Fig 3.6b. The magnetic heating
shows clear temperature dependence. In the frozen ferrofluid, only Néel heating
contributes since the particles are fixed and Brownian relaxation is absent. We
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fitted the magnetic heating power in frozen ferrofluid with theoretical power
contributed by Néel

(a)
(b)

Figure 3.6: (a) Ambient heating from -40 to -10 o C (open circle) and fit to equation
3.5 (solid line) (b) Magnetic heating after subtracting background in frozen
ferrofluid (open circle); solid line – theoretical Néel heating, dashed line –
theoretical Néel heating at slightly lower τ0 and higher K as compared to the values
obtained from solid line fit.
relaxation only by taking o =1.1x10-9 s, a magnetocrystalline anisotropy of
K=31x103 kJ m-3, and a magnetic core size of 12 nm. With the selection of these
parameters, theoretical Néel heating power fit very well with the experimental
data. However, the fit is very sensitive with the selection of these parameters since
the slight change of these parameters lead to different power, which is shown in Fig
3.6b for the slightly lower value of o and higher value of K. Ambient heating at low
temperature in frozen ferrofluid is described very well by the radiative heat
transfer. However, at the melting phase, where latent heat of melting is associated,
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and above melting phase, where convective heat transfer may be dominant, we
couldn‟t fit equation (3.5).
We have plotted experimental zero field (open circle) and field applied (closed
triangle) heating data in Fig 3.7a. Thes data were obtained by taking the derivative
of experimental data, temperature versus time, and multiplying dT/dt by the heat
capacity and mass of the sample. For the frozen ferrofluid, we took the heat capacity
of ice as 2108 Jkg -1oC-1 and for liquid ferrofluid, we took heat capacity of of water as
4187 Jkg -1o C-1. The mass of ferrofluid was 10 g. As expected, zero field power
decreases with increasing temperature and becomes zero at room temperature.
Also, the power is positive below room temperature and negative above room
temperature indicating heat gain and loss by the sample below and above room
temperature respectively. Field applied heating data shows higher power as
compared to zero field heating due to the presence of additional heating caused by
Néel and Brownian relaxation. Since we are unable to calculate the fraction of ice
remaining as a function of temperature, we haven‟t calculated the power at the
range of -2.5 to 2.5 o C. We have also calculated the magnetic heating power on
frozen ferrofluid and liquid ferrofluid by using polynomial fits to model the data.
Both zero field and field applied data on Fig 3.5b were fitted with polynomial and
power of heating was calculated as mentioned for Fig 3.7 a. After subtracting the
ambient power, only magnetic heating has been plotted in Fig 3.7b. In the frozen
ferrofluid, the magnetic heating, which is due to only Néel relaxation, increases
with increase in temperature upto approximately -15 o C, consistent with Fig 3.6 b.
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The magnetic heating in liquid ferrofluid is greater than that in frozen ferrofluid,
which is due to presence additional Brownian relaxation in liquid ferrofluid.
However, the magnetic heating in liquid ferrofluid varies from 8 W/g near 10 o C to

(a)

(b)

Figure 3.7: (a) Experimental heating power for ferrofluid with (closed triangle) and
without (open circle) magnetic field. No background correction. (b) Magnetic heating
power of ferrofluid after doing background correction using polynomial fit. Open
square is the magnetic heating power at 0 o C.
just about 5 W/g at 40 oC. This decrease in magnetic heating in liquid ferrofluid is
due to the temperature dependence of Néel and Brownian relaxation and also
change in viscosity with temperature. We also calculated magnetic heating power at
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0 o C by considering all the ferrofluid melted at 0 o C and is shown as a large square
in Fig 3.7b.

3.2.3 CONCLUSIONS
We synthesized iron oxide nanoparticles coated with dextran having
molecular weights of 5 kDa, 15-20 kDa, 60-90 kDa and 670 kDa. Their
hydrodynamic size was measured using DLS, AC magnetization and FCS
measurement. DLS and magnetic measurement gave sizes ranging from 90 to 140
nm, which is a factor of two larger than the size expected on the basis of physical
consideration. FCS measurement on 15-20 kDa dextran coated sample gave a
hydrodynamic diameter of about 55 nm, which is close to the expected value. We
conclude that FCS measurement provide a more accurate estimate of particle size in
dilute solutions than DLS and magnetic measurement. It is important to obtain
accurate size of nanoparticles since there are many biomedical application where
the size of nanoaprticles play a crucial role [92,93].
We did the magnetic hyperthermia measurement on ferrofluid from frozen
state to liquid state and calculated power produced by Néel heating alone in frozen
ferrofluid, and due to Néel and Brownian heating in liquid ferrofluid on the same
sample. We found that ambient heating in frozen ferrofluid can be modeled by
radiative heat transfer. We determined temperature dependent Néel heating in
frozen

ferrofluid, maximum

magnetic heating

in

melting

ferrofluid, and

temperature dependent Néel and Brownian heating in liquid phase of ferrofluid. .
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3.3 FATTY

ACIDS

COATED

IRON

OXIDE

NANOPARTICLES
Fatty acids are carboxylic acid with long chains of hydrocarbon. Their chain
lengths vary from 10 – 30 carbons. There are two types of fatty acids: saturated and
unsaturated. Fatty acids having only single bonds between carbon atoms are called
saturated since they are saturated with hydrogen and include lauric acid, myristic
acid, palmitic acid, and stearic acid, among others. Fatty acids with one or more
double bond between carbon atoms are referred as unsaturated since they need
hydrogen to saturate. Unsaturated fatty acids include oleic acid, erucic acid,
sapienic acid, and elaidic acid, among others. Unsaturated fatty acids have two
configuration, namely, cis and trans. In cis configuration, two adjacent hydrogen
aotms are on the same side of the double bond and offer flexibility to the chain
whereas in trans configuration two hydrogen atoms are on opposite side of the
double bond, which make the chain rigid. Fatty acids are not highly soluble in water
and this limited solubility decreases with an increase in chain length. Since fatty
acids are non polar, they dissolve readily in organic solvents such as cyclohexane,
benzene, chloroform, and toluene. Fatty acids play an important role in many
metabolic functions, such as moving oxygen through the bloodstream, assisting the
function and development of cell membranes, and preventing early aging among
others. Because of the many biomedical applications of fatty acids, we chose lauric
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acid, myristic acid, and oleic acid to coat iron oxide nanoparticles and studied the
magneto hydrodynamic properties of these nanocomposites.

3.3.1

EXPERIMENTAL DETAILS
We synthesized lauric acid (LA), myristic acid (MA) and oleic acid (OA)

coated iron oxide nanoparticles as described in section 2.1.2. X-ray diffraction
pattern of fatty acids coated iron oxide were taken using Cu Kα radiation on a
Rigaku Ru2000 rotating anode diffractometer to confirm the crystal structure of
nanoparticles. TEM images were taken using JOEL HR TEM 2010, operated at 200
kV, to get the core size of nanoparticles. Dynamic light scattering (DLS)
measurements were performed to determine the hydrodynamic size of LA, MA and
OA coated iron oxide nanoparticles dispersed in cyclohexane. These DLS
measurement used a 632.8 nm He-Ne laser with the scattered light collected at 90 o .
A 128-channel counter with 60 μs bin size was used to determine the correlation
function, which can determine particles size down to 10 nm.
We used a Quantum Design Superconducting Quantum Interference Device
(SQUID) to measure the DC magnetization as a function of temperature and
magnetic field, while the AC magnetization was measured using a standard option
in a Quantum Design Physical Property Measurement System (PPMS). For the
magnetic measurements, we used 30 mg of powder sample mounted in a gelatin
capsule and the sample was pressed with cotton to avoid any motion during the
measurement. We used slightly different set-up for the magnetic hyperthermia than
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the version presented section 3.2.1. These measurements used a 5 cm long coil with
80 turns. The current passing through the coil was 15 A at a frequency of 100 kHz,
which produced an alternating magnetic field of 300 Oe.
The Mössbauer spectra were collected in the transmission geometry using
both sides of a (Wissel) transducer coupled to cobalt 57 in Rh matrix sources of
about 50 mCi (29 Oct. 2007) or approximately 13 mCi at the time of the
measurements, and 256 channels of multichannel analyzers. A thin iron foil was
used for the velocity calibration and the linearity verification. Janis VT series
Cryostat was used to collect the Mössbauer spectra at 78 K. Approximately 70 mg of
the sample were uniformly distributed in a Teflon circular cell of 1.7 cm diameter
for the Mössbauer measurement. The isomer shift values are reported with
reference to iron and the spectra were least square fitted with MossWin program.
For magneto-optic measurements, 0.4 ml of liquid ferrofluid in a standard
quartz suprasil spectrophotometer cuvette having a 1 mm path length was placed
between a pair of water-cooled Helmholtz coils, which could produce a DC magnetic
field of 400 Oe. A He-Ne laser beam (λ = 632.8 nm) of power 10 mW was
transmitted through the sample perpendicular and parallel to the applied field and
the scattered light patterns were collected on a 220 mm x 220 mm translucent
screen placed at distance of 500 mm from the sample. The time dependent images of
field induced scattering patterns on the screen were taken and analyzed by image
analysis software to produce 2D map of scattered light intensity.
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3.3.2

RESULTS AND DISCUSSIONS
X-ray diffraction patterns of LA, MA and OA coated iron oxide nanoparticles

are shown in Figs 3.8 a, b and c respectively. All the peaks can be labeled to the

Figure 3.8. XRD patterns for (a) lauric acid (LA), (b) myristic acid (MA), and (c) oleic
acid (OA) coated Fe3O4 nanoparticles. Taken from R. Regmi et al., J. Appl. Phys.
106, 113902 (2009).
Bragg reflections expected for Fe 3O4. We also calculated the size of
nanoparticles from the most intense peak, the (311) reflection, using the Debye
Scherrer equation, d=(0.9λ)/βcosθ, where β is the full width half maximum (FWHM)
of the peak. This yielded values of 12.3, 11 and 10.5 nm for the crystallite size for
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LA, MA and OA coated samples respectively. We also calculated the size of the
nanoparticles from two more intense peaks, (440) and (333), and found an
uncertainty of approximately 2 nm on the size of nanoparticles. TEM images of LA,
MA and OA coated iron oxides are shown in Figs 3.9a, b and c respectively. We
measured the size of many nanoparticles manually to plot the histogram, which was
fitted by a log normal distribution, shown in the inset of Fig 3.9a, b and c for
corresponding particles. All the nanoparticles were about 12 nm with a standard
deviation of 2 to 3 nm. The sizes of nanoparticles along with standard deviation are
given in Table I.

Figure 3.9. TEM images for (a) lauric acid, (b) myristic acid, and (c) oleic acid coated
Fe3O4 nanoparticles. For all images the scale bar shows a length of 100 nm. The
insets show a histogram of the particle sizes, with the solid line showing a fit to a
log-normal distribution. Taken from R. Regmi et al., J. Appl. Phys. 106, 113902
(2009).
We did thermogravimetric analysis (TGA) measurements for all three fatty
acid coated nanoparticles along with bare Fe 3O4 to determine the amount and
number of coated layers of surfactants for these nanocomposite materials. The TGA
curves for these samples are shown in Fig. 3.10. For the LA, MA and OA coated
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samples, there is a weight loss of 12, 15, and 31% respectively, showing single step
transition close to 400

o C.

This single step transition implies that there is a

monolayer coating of LA, MA, and OA on the corresponding particles. We also found
a 3-4% loss in weight in the bare Fe 3O4 nanoparticles at lower temperatures. We
attribute this decrease to adsorbed moisture or hydroxyl groups on the surface of
the bare Fe3O4. Although these measurements were done in a nitrogen atmosphere,
we found a weight gain for these nanoparticles at higher temperature due to the

Weight % (%)

oxidation of nanoparticles.

100

80
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MA-Fe3O4
OA-Fe3O4
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Figure 3.10. Thermo Gravimetry Analysis (TGA) for bare Fe 3O4 nanoparticles,
lauric acid, myristic acid, and oleic acid coated samples.
We used DLS to determine the hydrodynamic size of fatty acid coated
nanoparticles in the cyclohexane solvent. We fitted the autocorrelation function
obtained from the DLS measurement and extracted the relaxation rate Γ at the
wave vector q=(4πnsin(θ/2))/λ 0, where θ=90o , λ0=632.8 nm and refractive index of
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cyclohexane,

n=1.44. Using

Γ=Dq2

and

D=kBT/6πηR,

we

calculated

the

hydrodynamic radius of each nanoparticle by using the viscosity of cyclohexane 0.98
cP. The DLS sizes of LA, MA and OA coated nanoparticle s are given in Table 3.1.
Since the chain lengths of LA, MA and OA are 1.6, 1.8 and 2.0 nm respectively, the
hydrodynamic diameter of these polymer coated nanoparticles are approximately
twice that calculated on the basis of the chain length of a single layer coating of
surfactant added to the core size of the nanoparticles. We repeated the DLS
measurement on these samples after a six month period and found the same result,
Samples

Ms
(emu/g)

DXRD (nm)

DDLS(nm)

DTEM (nm)

±2 nm

σH (nm)
TEM

±3 emu/g
Fe3O4 LA

58

12.3

32

11.6

3.3

Fe3O4 MA

62

11

34

11.9

2.9

Fe3O4 OA

58

10.5

36

12.3

3.1

Table 3.1: Properties of ferrofluid nanoparticles coated with surfactants of varying
chain lengths; Ms – saturation magnetization, scaled by the Fe 3O4 mass fraction in
the composite; DXRD – crystalline diameter from XRD; DDLS – hydrodynamic
diameter from DLS as discussed in the text; DTEM – solid diameter from TEM; σH –
standard deviation in DTEM.
precluding the possibility of agglomeration accounting for the overestimation of the
size. Similar discrepancies in the measured size of polymer coated nanoparticles
have been reported in the literature previously [55,56]. Since the hyperfine field is
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sensitive to Fe valence, we collected Mössbauer spectra to differentiate Fe3O4 , which
contains both divalent and trivalent Fe, from γ-Fe2O3, which contains only trivalent
Fe. We show the data for only the LA coated sample in Fig. 3.11, as the Mössbauer
spectra of all LA, MA and OA coated samples were qualitatively and quantitatively
similar. The values of the fitted Mössbauer parameters for LA-Fe3O4 are listed in
Table 3.2. As described in section 2.2.11, the isomer shift (δ), quadrupole splitting
(Δ) and hyperfine field (H) give information about the valence states of iron and
their occupancy in the crystal lattice.

Figure 3.11: 57Fe Mossbauer spectra for lauric acid coated Fe 3O4 nanoparticles at
(a) 300 K (b) 78 K. Open rectangle, dot, dash dot, cross and solid line represent
experimental data, 1st sextet, 2nd sextet, doublet and fitted to two sextets and one
doublet respectively. Taken from R. Regmi et al., J. Appl. Phys. 106, 113902 (2009).
The flipping frequency of the net magnetization in non-interacting magnetic
nanoparticles is given by f=f0exp(-KV/kBT) where K is the magnetocrystalline
anisotropy constant, V is the volume of a nanoparticle, f0 is the microscopic attempt
frequency (typically in the order of 10 12 Hz), and T is the temperature. For f<<fobs,
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the

observation

frequency

during

the

experiment

(108

Hz

for

57Fe),

superparamagnetic fluctuations are suppressed, and a six line Mössbauer pattern is
observed. For f>>fobs, the superparamagnetic fluctuations are dominant, and the six
line pattern collapses into a quadrupole doublet or a singlet. However, because of
the exponential dependence of f on the nanoparticle volume and the size
polydispersity of these nanoparticles, both six line patterns and quadrupole
doublets can be observed in the same spectrum.
Samples

T = 300 K
H ±1.5

T = 78 K

δ ±0.04

H ±1.5

Δ±0.04
(kOe)

Δ±0.04
(mm/s)

(kOe)

(mm/s)
Fe3O4 LA

δ ±0.04

(mm/s)

(mm/s)

466

0.31

0.01

520

0.45

0.01

414

0.36

0.02

499

0.40

0.10

Table 3.2- Mossbauer parameters for LA coated Fe 3O4 nanoparticles; H- hyperfine
magnetic field;  - isomer shift; Δ – quadrupole splitting.
At 300 K, where the nanoparticles moments have sufficient thermal energy to
fluctuate freely, the Mössbauer spectra of the lauric acid coated sample shown in
Fig. 3.11a were fitted using two sextets at hyperfine field of H1 = 466 kOe and H2 =
414 kOe. H1 is produced by Fe3+ at a tetrahedral A-site and the octahedral B-site of

73

a spinel ferrite whereas H2 is produced by a mixed valence state, Fe 2.5+, at
octahedral B-site due to the electron hopping mechanism between Fe 2+ and Fe3+
[94]. Additionally, the spectrum also has a quadrupole doublet with isomer shift (δ)
= 0.33 mm/s and quadruple splitting (Δ) = 0.58 mm/s, which is characteristic of the
presence of superparamagnetic Fe3O4 nanoparticles.
There are no thermal fluctuations at 78 K because of the freezing of the
nanoparticles moments below the blocking temperature of about 150 K for lauric
acid coated nanoparticles. The Mössbauer spectra of the lauric acid coated sample
shown in Fig. 3.11b were fitted using two sextets at hyperfine field of H 1 = 520 kOe
and H2 =

499 kOe. These values are in agreement with the literature value of

magnetite phase [94]. This observation also precludes the presence of other phases
of iron oxide, such as hematite or goethite, where iron is present at only one
crystallographic site. Also, it discounts the presence of γ-Fe2O3 since Fe3+ on both A
and B sites have same value of hyperfine field, 510 kOe.
We did DC magnetization measurements for the LA, MA, and OA coated
nanoparticles. The magnetizations as a function of DC magnetic field for all three
samples are shown in the inset of Fig 3.12. The LA, MA and OA coated
nanoparticles have saturation magnetization of 58, 62, and 58 emu/g of Fe 3O4
respectively, excluding the mass contribution from surfactants determined from
TGA. These values are given in Table I with an uncertainty of 3 emu/g of Fe3O4,
which is due to the uncertainty in weight of the sample for TGA and magnetic
measurements. The saturation magnetization of these nanoparticles is smaller than
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the bulk value of Fe3O4, 90 emu/g, which can be attributed to the presence of a

20
M (emu/gcomposite)

M(emu/gcomposite)

disordered surface spin layer in nanoparticles [95].
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Figure 3.12: Zero-Field cooled (ZFC) and Field cooled (FC) magnetization curves for
lauric acid coated Fe3O4. Inset: Room temperature magnetization as a function of
field for lauric acid, myristic acid, and oleic acid coated Fe 3O4. These plots show the
magnetization scaled by the total mass of the composite system.
Also, the surfactant coating can further reduce the saturation magnetization of
magnetic nanoparticles by making more disordered surface spins [96].
The single valued M(H) curve at room temperature implies that these
nanoparticles are superparamagnetic. This is also confirmed by superparamagnetic
blocking crossover observed in the field cooled (FC) and zero field cooled (ZFC)
magnetization measurements. Since all the fatty acids coated nanoparticles showed
similar behavior, we have shown representative ZFC and FC curves under a
measuring field of 200 Oe for the LA coated iron oxide nanoparticles. The ZFC curve
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shows a broad maxima at 150 K, indicating a ploydispersity of the nanoparticles,
consistent with TEM images and the room temperature Mössbauer results.
We also did the AC magnetization measurement on lyophilized samples of
LA, MA and OA coated nanoparticles to probe the dynamics of the blocking
transition. Again, we show only a representative curve for the LA coated sample.
The imaginary part of the AC susceptibility as a function of temperature at three

M"(10-2emu/gcomposite)

different frequencies is shown in Fig. 3.13.
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Figure 3.13: Temperature dependence of the out-of-phase component of the ac
susceptibility of lauric acid coated Fe3O4 nanoparticles measured at 100 Hz, 1 kHz,
and 10 kHz.
Since the sample was lyophilized,Brownian relaxation is completely suppresses so
the peak in AC loss is associated only with Néel relaxation. As the peak
temperature increases with increasing frequency, we used the Arrhenius equation,

f=f0exp(-EA/kBT), to estimate the activation energy (EA) and characteristic frequency
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(f0) of the moment reversal. We found EA~ 570 meV with f0~2.8 x 1016 Hz for the LA
coated sample, E A~ 490 meV with f0~1.6 x 1014 Hz for MA coated sample and E A~
530 meV with f0~1.1 x 1014

Hz for OA coated sample. We had also done AC

magnetization measurement for bare Fe3O4 yielding E A= 348 meV with f0=7.2 x 010
Hz, which are systematically smaller than the values obtained for the fatty acids
coated samples. The difference may be due to the change in surface spin properties
for surfactant coated nanoparticles. The peak at lower temperature, 50 K, is likely
due to the disordered surface spins freezing into spin-glass-like state [97].
These AC and DC magnetization and Mössbauer measurements show that
the magnetic properties of nanoparticles are independent of surfactant coating,
which allows us to investigate how the magneto hydrodynamic properties depend on
the surfactant, without concern to differences in the magnetic reponse of the
nanoparticles. As a first study, we investigated the magneto hydrodynamic response
of different chain length fatty acids coated samples by magnetic hyperthermia. We
applied a 300 Oe alternating magnetic field at the frequency of 100 kHz to 1 mL of
LA, MA and OA coated iron oxide dispersed in cyclohexane. The rise in temperature
is shown in Fig 3.14. We also calculated the specific absorption rate (SAR) using the
following relation:

SAR =

CL L T
( ) …………………………………………………..(3.6)
 t
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Figure 3.14: Rise in temperature as a function of time for lauric acid (open
rectangle), myristic acid (open circle) and oleic acid (open star) coated Fe3O4 along
with carrier liquid cyclohexane(open triangle). Inset: SAR plotted against chain
length.
where C L and ρL are the specific heat and density of the carrier liquid, φ = weight
concentration of the magnetic nanoparticles in the ferrofluid, and

T
is the rate of
t

increase in the temperature. Substituting C L=1.83 kJ/kg-K and ρL= 0.78 g/cm3 for
cyclohexane, ϕ = 5 mg/ml, and

T
as the initial slope of the curve, we found the SAR
t

for LA, MA and OA coated sample to be 37, 46, and 64 W/g respectively. The
differences in these values reflect the contribution of Brownian relaxation, which
depends on the chain length and hydrodynamic size of the nanoparticles. Since the
magnetic properties are similar for all fatty acid coated samples, the contributions
from Néel relaxation are practically identical for all samples. The SAR values are
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plotted as a function of chain length in the inset of Fig. 3.14, which implies that the
SAR increases approximately linearly with the chain length of the surfactants.
The magneto-hydrodynamic response of the ferrofluids was also investigated by
dc magnetic-field-induced anisotropic light scattering patterns. An anisotropic
interaction between the induced dipoles of nanoparticles in the presence of the dc
magnetic field caused them to from chain like structure. These chain like structures
have been studied extensively both theoretically and experimentally [98-100]. The
self-assembly results in a strong anisotropy of the scattering patterns for the light
propagating through the ferrofluid in the presence applied magnetic field [98,101].
The time evolution of these patterns is used to investigate the hydrodynamic
response of nanoparticles in solution [98,101].
We observed strong anisotropy for all three samples for the light propagating
perpendicular (Figure 3.15a) to the direction of applied field as compared to the
light propagating parallel to the direction of applied field (Figure 3.15b). We used
the framework and system notations introduced in reference [98] for a quantitative
description of the patterns. The time-dependent optical anisotropy factor A(h,t) is
defined as:

A(h, t )  2

I  (h, t )  I|| (h, t )
I  (h, t )  I|| (h, t )

…………………………………….(3.7)

where I   I (h,   / 2) is the intensity of light scattered perpendicular to the field
and I||  I (h,   0)  I (h,    ) is the intensity of light scattered parallel to the
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Figure 3.15: Time dependent light scattering patterns in a 400 Oe applied magnetic
field at representative instants of time after turning ON the magnetic field for light
propagating (a) perpendicular to the field and (b) parallel to the field. Taken from R.
Regmi et al., J. Appl. Phys. 106, 113902 (2009).
magnetic field. These notations are explained in reference [98]. Scattering patterns
(Figures 3.15a and 3.15b) show that I || (h)  I  (h) , which is also is reflected in the
angular dependence of the scattered intensity of MA coated sample shown in Figure
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3.16 for several value of scattering vector h. This suggests the development of
anisotropic nanoparticle chains and columns.
Time evolution of optical anisotropy factor A for LA, MA and OA coated sample is
shown in Fig 3.17 for the median value of scattering vector h = 60 mm. We observed
correlation between the kinematics of chain formation and optical anisotropy
constant depending on the chain length of the surfactant. We found that the time
evolution of larger chain length OA coated sample is slower than other samples. We
also observed fluctuations of A for LA and OA coated samples for time 0 < t < 1500 s

Intensity (arb. units)

after turning the magnetic field ON. Similar fluctuations in A (Figure 3.17) were
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Figure 3.16: Angular dependence of the intensity of scattered light for the myristicacid coated sample.
observed for all three surfactant coated sample while turning the field OFF. Shorter
chain length LA (C 12 chain length) coated sample has shown larger fluctuations
while switching the field OFF whereas longer chain length OA coated sample (C 18
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chain length) has shown more fluctuations while switching the field ON. We also
observed remnant magnetism in all there sample after removing external magnetic
field persisting to a time scale of hours. OA coated sample has shown maximum
remanance and anisotropic properties as compared to other samples. The theory of
fluctuation-mediated long range lateral chain interaction was first proposed by
Halsey and Torr [99], and have also further investigated by others [102-104].

Figure 3.17: (Color on-line) Time dependence of the optical anisotropy parameter A
at the median value (h = 60 mm) of the scattering vector for the oleic acid, myristic
acid and lauric acid coated nanoparticles with field ON and OFF. Taken from R.
Regmi et al., J. Appl. Phys. 106, 113902 (2009).
Since the scattering pattern is sensitive to chain-chain separation, the fluctuation
in OA and LA coated sample reflects the chain formation during field ON and
deformation during field OFF.,
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3.3.3

CONCLUSION
We investigated the magnetic and magnetohydrodyanmic properties of lauric

acid, myristic acid, and oleic acid coated iron oxide nanoparticles. The magnetic
properties did not vary significantly among the different surfactant coating.
Conversely, the magnetic heating and magneto-optic properties did depend on the
hydrodynamic size, which varied over the different chain length fatty acids coated
iron oxide nanoparticles. In magnetic heating, the specific absorption rate (SAR)
increases with increase in chain length. Magneto-optic measurement also suggested
strong surfactant dependent optical anisotropy. This implies that magnetic
nanoparticles with different hydrodynamic size respond differently in the presence
of

both

AC

and

DC

magnetic

field,

which

allows

us

to

control

the

magnetohydrodynamic properties of magnetic nanoparticles by coating them with
different chain length surfactants.

3.4 SUMMARY
We synthesized iron oxide nanoparticles coated with different chain lengths
of dextran varying from 5 kDa to 670 kDa. Measurement of hydrodynamic size on
these nanoparticles by three different techniques namely DLS, AC magnetization
and FCS suggests that FCS measurements on polymer coated nanoparticles give
the most accurate hydrodynamic size whereas DLS and magnetic measurement find
diameters a factor of two larger than expected from physical considerations.
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We also did magnetic hyperthermia measurement on the 15-20 kDa dextran
coated sample continuously from the frozen to the liquid phase to differentiate the
contributions of Néel and Brownian heating. These measurements suggested that
magnetic heating due to Néel and Brownian relaxation are temperature dependent.
We also found significant magnetic heating in the inhomogeneous melting phase of
the nanoparticles as compared to the heating on frozen and liquid ferrofluid, which
may be because of enhanced Brownian relaxation due to finite size effects, capillary
forces in inhomogeneous melting phase, and increased viscosity at low temperature.
We studied the magnetohydrodynamic properties of different chain length
fatty acids (lauric, myristic and oleic acid) coated iron oxide nanoparticles. We found
that the magnetic properties of these nanoparticles do not vary with different
surfactant coating, unlike the magnetohydrodynamic properties. Different chain
length surfactants change the hydrodynamic size of nanoparticles, which modifies
the Brownian relaxation. This means that the magnetic heating and magneto-optic
properties of liquid ferrofluid, both of which depend on Brownian relaxation of
nanoparticles, also vary with the chain lengths of surfactant coatings.

This

provides another handle to tune the response of magnetic nanoparticles in solution
without changing the magnetic response of the particles.
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CHAPTER 4
DRUG DELIVERY USING MAGNETIC
NANOPARTICLES
4.1 INTRODUCTION
Delivering drug to specific sites and at specific concentrations in vivo increase
their therapeutic effects and minimizes potentially dangerous side effects. Many
non-magnetic drug carriers have been used for the targeted drug delivery, but most
of these lack good targeting and are cleared up by the reticuloendothelial system
(RES). The RES is a part of immune system and engulfs foreign object, harmful
bacteria and virsues, and also ingests abnormal and old cells in our body. Magnetic
nanoparticles have a number of advantages for targeted drug delivery, including: 1)
they can be controlled by non-invasive external magnetic field to accumulate at
specific site in vivo 2) their surface can be modified to attach ligands to target
specific site in vivo 3) they are small enough to accumulate inside cells 4) they can
be heated by applying non-invasive external alternating magnetic field to release
the drug 5) they acts as contrast agent and their distribution inside body can be
monitored by using magnetic resonance imaging and 6) iron oxide magnetic
nanoparticles are biocompatible and has food and drug administration (FDA)
approval to use in vivo. Given the great potential of iron oxide nanoparticles for
targeted drug delivery, we have studied drug release from a thermosensitive
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polymer

Poly-N-isopropylacrylamide

(PNIPAM)

triggered

by

magnetic

hyperthermia. In addition, we have also studied the drug release from different
molecular mass dextran coated iron oxide nanoparticles to investigate the effect of
chain length on the drug release profile.

4.2 HYPERTHERMIA CONTROLLED DRUG RELEASE
FROM MAGNETIC MICROGELS
Poly-N-isopropylacrylamide (PNIPAM) is a biocompatible and stimuliresponsive polymer having a number of biomedical application including controlled
drug delivery, artificial muscles, cell adhesion mediators, and precipitation of
proteins [105-109]. PNIPAM shows a reversible volume changing phase transition
associated with a structural coil-to-globule conformational change in solution above
the lower critical solution temperature (LCST) of 305 K (32 o C) [110-113]. PNIPAM
absorbs water and swells below the LCST while it shrinks and release
hydrophobically bound water above the LCST. This property has been used for
studies of controlled drug release using PNIPAM [114,115]. There has been
considerable interest to synthesize nanocomposites with stimuli-responsive polymer
and metal and metal oxide for chemotherapy drug release [116-122]. In these
nanocomposites, nanoparticles are embedded in cavities or polymer shells and
immobilized by entanglement or covalent bonding with the chains. In the proposed
chemotherapy delivery vehicle, the hybrid composite material consisting of
PNIPAM and iron oxide nanoparticles is loaded with the drug to be delivered and
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injected in the vasculature surrounding the target tumor. Incorporating iron oxide
nanoparticles in the polymer matrix provides a number of benefits, including: 1)
the ability to determine the distribution profile of the drug attached to the
PNIPAM/magnetite composite using Magnetic Resonance Imaging 2) the possibility
of remotely and controllably releasing the drug by the non-invasive application of
an external magnetic field, and 3) increasing the efficacy of the drug by locally
heating the tumor site.
In a recent study by Purushotham et al. [120] magnetite was incorporated in
the PNIPAM matrix and the composite showed the drug release at the rate 0.001
mg/ min when heated from 310 to 321 K (37 to 48 o C) over a total time of 47 min.
Hoare et al. [119] showed drug release of ~0.012 mg/min in the same system over a
time interval of 35-75 min.

These studies show substantial drug release can be

produced solely by magnetic heating, but the timescales involved are relatively long.
However, if this targeted drug release is to be combined by magnetic hyperthermia
therapy, the elevated temperatures should be maintained only for much shorter
time periods to avoid damaging the surrounding cells. The objective of our study is
to investigate the in vitro burst release of chemotherapy drugs loaded into a
PNIPAM/nanoparticles composite, driven solely by the heating produced by an
external magnetic field in a short interval of time . We selected mitoxantrone as the
model anti cancer drug because its effectiveness increases at 316 K (43 o C), making
it a

suitable candidate

applications [123].

for combined targeted drug

release/hyperthermia
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4.2.1 EXPERIMENTAL DETAILS
Magnetite nanoparticles having a diameter of roughly 12 nm were prepared
by a co-precipitation method described in detail in section 2.1.1. The PNIPAM
microgels were synthesized by a free radical polymerization technique as described
in section 2.1.6. Thermogravimetric analysis between 315 K and 1000 K, shown in
Figure 1, established that the resulting PNIPAM-SA-Fe3O4 composite contained 50
% iron oxide by mass, as indicated by the sharp drop in sample weight at the
polymer dissociation temperature. This dissociation temperature can be determined
more precisely by plotting the temperature derivative of the thermogravimetric
response (also shown in Figure 4.1). This decomposition temperature is found to be
very close to 600 K.

0.2
0.0

90

-0.2

80

-0.4

70
60

-0.6

50

-0.8
450

600

750

dW/dT (%/K)

Weight (%)

100

900

T (K)
Figure 4.1: Thermogravimetric weight as a function of temperature for PNIPAMSA-Fe3O4 (lighter line) and the temperature derivative of the weight (dark line).
In order to increase the colloidal stability of the composite, we had added 60 mg of
sodium poly(styrene-sulfonate) (PSS) to the magnetic microgels since PSS has a
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sulfonate group (SO3-), which creates negative charge on the surface of the
PNIPAM-SA-Fe3O4 and helps to avoid agglomeration by electrostatic repulsion
making well dispersed ferrofluid.

We

imaged

the

PNIPAM-SA

parent

microgels and PNIPAM-SA-Fe3O4 magnetic microgels using a Hitachi S-2400
Scanning Electron Microscope (SEM) and a Jeol-2010 FasTEM Transmission
Electron Microscope (TEM). The dynamic light scattering (DLS) measurements
were performed using a 90 Plus particle size analyzer from Brookhaven Instrument
Corporation to investigate samples of PNIPAM-SA and PNIPAM-SA-Fe3O4
dissolved using deionized water as a solvent. We measured the dc magnetization of
dry PNIPAM-SA-Fe3O4 and ac magnetization of a solution PNIPAM-SA-Fe3O4,
using DI water as the carrier liquid, using the standard ACMS option on a
Quantum Design

Physical Property

Measurement System (PPMS).

The

thermodynamics of the phase transition of the PNIPAM/nanoparticle composites
was investigated using a Q 2000 DSC system (TA Instruments, Delaware, USA).
Samples of PNIPAM-SA, PNIPAM-SA-Fe3O4 and bare Fe3O4 nanoparticles were
prepared at concentration of 5 mg/ml in DI water. The samples were scanned from
283 to 323 K at a scan rate of 3 K/min under a continuous nitrogen stream. TA
universal analysis software extracted both the transition temperature and ΔH,
which was determined from the area under each peak.
The magnetic heating was accomplished using an RF generator model CLX2750 (COMDEL) to produce an alternating magnetic field having an amplitude of
approximately 130 Oe at a fixed frequency of 380 kHz. The samples, consisting of 50

89

mg of PNIPAM-SA-Fe3O4 loaded with the anticancer drug mitoxantrone dispersed
in 0.5 ml phosphate buffer solution with pH 7.4, was place d inside a 40 turn
induction coil of length 8.5 cm and surrounded by a high density Styrofoam
insulation to prevent direct heat transfer from the coil to the sample. The
temperature of the solution was measured using an IR thermometer having a
temperature resolution of +/- 0.6 o C. The amount of drug released from the magnetic
microgel at different points in the experiment was determined by using a Cary 50
Bio, UV-Visible spectrophotometer to measure the transmission of liquid decanted
from the sample. A phosphate buffer with a pH 7.4 was used as the solvent. In order
to compare the magnetically induced drug release with conventional heating
methods, we also investigated the release from PNIPAM-SA loaded with
mitoxantrone heated in a standard water bath.

4.2.2 RESULTS AND DISCUSSIONS
We imaged the PNIPAM-SA and PNIPAM-SA-Fe3O4 microgels using
scanning

electron

microscopy

and

the

PNIPAM-SA-Fe3O4

sample

using

transmission electron microscopy, as shown in Fig. 4.2. Figs 4.2a and b present
SEM images for PNIPAM-SA and PNIPAM-SA-Fe3O4 respectively, showing the
typical lengthscale for these polymer globules, being 360 nm for PNIPAM-SA and
200 nm for PNIPAM-SA-Fe3O4. While it is difficult to unambiguously establish the
sample morphology, the TEM images of PNIPAM-SA-Fe3O4, Figs 4.2c and d,
suggest that the Fe3O4 nanoparticles partially coat the polymer. Some PNIPAM-SA
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Figure 4.2: (a) SEM image of PNIPAM-SA (b) SEM image of PNIPAM-SA-Fe3O4. (c),
(d) TEM images of PNIPAM-SA-Fe3O4. Taken from R. Regmi et al ., J. Mater.
Chem., 20, 6158 (2010).
globules appear to almost completely coated, while others are completely devoid of
the nanoparticles. This inhomogeneous distribution of magnetic nanoparticles may
adversely affect the response of the composite, since only a fraction of the PNIPAM
polymer will be directly affected by nanoparticle heating. There is also evidence for
the presence of small Fe3O4 nanoparticle agglomerations that are not bound to the
PNIPAM-SA framework. This heterogeneous distribution of Fe 3O4 on the PNIPAMSA globules may develop due to surface-mediated nanoparticle agglomeration.
To further probe the geometry of the microgels and to determine the LCST
for the PNIPAM-SA and the magnetic PNIPAM-SA-Fe3O4 samples, we performed
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dynamic light scattering (DLS) measurements at different temperatures, as shown
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in Figure 4.3.
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Figure 4.3: Hydrodynamic diameter as a function of temperature for the PNIPAMSA-Fe3O4 composite, as determined using dynamic light scattering measurements.
Inset: Hydrodynamic diameter versus temperature for PNIPAM-SA.
It is known that pure PNIPAM has a LCST of 305 K, which we find increases to 310
K with the addition of hydrophilic sodium acrylate [124]. This is shown in the inset
to Figure 4.3, which illustrates the volume collapse from a hydrodynamic size of
almost 540 nm to approximately 240 nm at this temperature. The addition of Fe 3O4
nanoparticles shifts the LCST very slightly to 311 K. More remarkably, the size of
the PNIPAM-SA-Fe3O4 microgel is considerably reduced compared to the parent
compound, to only 270 nm, and the fraction change in volume is also much smaller,
only 12% for PNIPAM-SA-Fe3O4 as compared to 56% for PNIPAM-SA. The
reduction in the size of PNIPAM-SA after incorporating Fe3O4 nanoparticles may be
because of an increased cross-link density due to the presence of iron oxide
nanoparticles [40]. Steric hindrance and nanoparticle-nanoparticle interaction
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caused by the presence of iron oxide nanoparticles might have hampered the
polymer aggregation during LCST, which increased the LCST of PNIPAM-SA-Fe3O4
slightly and also caused a smaller change in volume during LCST in PNIPAM-SAFe3O4 [40].

The microgel sizes extracted from DLS measurements are somewhat

larger than what we obtain from SEM and TEM images (Fig. 4.2), which reflects the
fact that DLS is sensitive to the hydrodynamic radius of the composites in solution
while the electron microscopy images may reflect some volume collapse in the
microgel out of solution.
The heat flow out of the sample as a function of temperature for the
PNIPAM-SA and PNIPAM-SA-Fe3O4 composites and for bare Fe3O4 is shown in Fig.
4.4.

Heat Flow (W/g)

-0.24

-0.26

-0.28

PNIPAM-SA-Fe3O4
PNIPAM-SA
Bare Fe3O4

304

312

320

T (K)
Figure 4.4: Heat flow as a function of temperature measured by differential
scanning calorimetry for bare Fe3O4 (dotted line), PNIPAM-SA (dashed line), and
PNIPAM-SA-Fe3O4 (solid line) samples.

93

For the PNIPAM-SA and PNIPAM-SA-Fe3O4 traces, endothermic peaks occur near
308 K and 309 K with changes in enthalpy of approximately 2.34 J/g and 1.04 J/g
respectively. The temperatures of these peaks are consistent with the LCST of
PNIPAM-SA and PNIPAM-SA-Fe3O4 found using DLS measurements, and the
magnitude of the enthalpy for the PNIPAM-SA sample is consistent with previous
results in the literature [125]. The smaller change in enthalpy for the PNIPAM-SAFe3O4 sample, as compared to PNIPAM-SA, can be associated with a change in the
hydration state of the PNIPAM chains arising from the attachment of Fe3O4
nanoparticles. The bare Fe3O4 sample does not show any endothermal peak,
confirming that the features observed at 308 K and 309 K are due to a structural
change in the PNIPAM polymer component.
The magnetic relaxation time τ for the system depends on both Brownian
and Néel relaxation, so the frequency dependence of the magnetic susceptibility
yields information on changes in these mechanisms. We have measured the inphase and out-of-phase components of the complex susceptibility of the PNIPAMSA-Fe3O4 ferrofluid as a function of temperature and applied field frequency
through the LCST transition. Fig. 4.5a shows the out-of-phase component of the ac
susceptibility as a function of temperature for this sample, measured at a frequency
of 1000 Hz. This curve shows a clear maximum close to 308 K, corresponding to the
LCST of the microgel. At this transition temperature, the PNIPAM-SA polymer
changes to a hydrophobic state producing a sharp drop in the hydrodynamic volume
of the microgel. In turn, this increases the frequency of Brownian relaxation given
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by [126] fB=kBT/3ηV H, producing a peak in the magnetic dissipation. This anomaly
in the magnetic dynamics can also be seen by considering the variation of the
resonant frequency with temperature. The inset to Fig. 4.5a plots the resonant
frequency, determined from the peak in M‟‟ versus f plots (not shown), at different
temperatures.
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Figure 4.5: (a) Out-of-phase component of the ac magnetic susceptibility measured
as a function of temperature for PNIPAM-SA-Fe3O4. Inset: Peak frequency as a
function of temperature. (b) Room temperature magnetization curve measured for
PNIPAM-SA-Fe3O4.
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The saturation magnetization Ms, remnant magnetism Mr and coercivity Hc are the
most important parameters for assessing the suitability of magnetic materials for
applications. We plot the room temperature M (H) curve measured for lyophilized
PNIPAM-SA-Fe3O4 in Fig. 4.5b. The saturation magnetization of the composite is 33
emu/g of composite, as compared to approximately 68 emu/g for the bare Fe 3O4
nanoparticles used in the composite. This implies PNIPAM-SA-Fe3O4 contains
approximately 50% iron oxide by mass, which is consistent with our estimates of the
composition using TGA (see Fig. 4.1). Because of the higher concentration of iron
oxide in PNIPAM-SA-Fe3O4, the Ms value is relatively large as compared to typical

Ms values of such a hybrid material such as 10 emu/g for Fe18PNIPAM-AAS to 20
emu/g for Fe38PNIPAM-AAS [40] consistent with the larger mass fraction of Fe 3O4
in the microgel. The advantage of the higher value of magnetization of the sample is
that it can readily respond to the externally applied alternating magnetic field,
although higher iron oxide fractions can negatively impact drug loading fractions in
some composites [127]. The sample is also non-coercive at room temperature, which
is typical for superparamagnetic nanoparticles, making the composite suitable for
biomedical applications.
Having established that a conformal transition occurs in the PNIPAM-SAFe3O4 microgel at approximately 311 K, we investigated the possibility of using
external magnetic fields to heat this composite on short timescale. We plot the
increase in the temperature of PNIPAM-SA-Fe3O4 samples having different
concentrations of magnetic nanoparticles during the application of an external
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magnetic field in Fig. 4.6. There is some increase in temperature for the background
buffer solution, which may be associated with resistive heating in the induction coil.
There

is a systematic increase in the magnetic component of heating with

nanoparticle concentration. On this plot, the LCST for the composite (see Fig. 4.3)
corresponds to a ΔT of approximately 13 K, which is reached within 3 min of
applying the external magnetic field. We also note that local temperatures of 314-
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Figure 4.6: Change in temperature of PNIPAM-SA-Fe3O4 as a function of time
under magnetic hyperthermia, for nanoparticle concentrations ranging from 25
mg/mL to 100 mg/mL as indicated. The open symbols show the response of buffer
solution, used as a background control.
318 K are sufficient to kill cancer cells [128], which are obtained within 4 min for
the samples having higher concentrations of magnetic nanoparticles.
Having established that magnetic hyperthermia can be used to heat the
sample above the LCST, we investigated the loading and release of the anticancer
drug mitoxantrone in both the PNIPAM-SA and PNIAPM-SA-Fe3O4 composites. To
load the samples, we stirred a mixture consisting of 1 mg/ml of mitoxantrone and 25
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mg/ml of microgel for 12 hours under ambient conditions. The drug loading fraction
was determined to be 100% in PNIPAM-SA-Fe3O4 and 65% in PNIPAM-SA. It is
unclear why drug loading is more efficacious in the magnetic composite, although
this may be related to the electrostatic effects discussed in the following. The drugloaded PNIPAM-SA-Fe3O4 composite was heated using only an applied magnetic
field from 298 to 323 K in 4 min, while the drug-loaded PNIPAM-SA sample was
heated over the same range of temperatures in 30 min using a water bath. While
the drug release fraction determined by following this particular measurement
protocol represents a convolution of the release rate at different temperatures with
the warming rate, we believe that it provides a useful insight into the release
dynamics that will be relevant for clinical applications. However, as the heating
rate is relatively constant, as illustrated in Fig. 4.6 for the PNIPAM-SA-Fe3O4
composite, we can identify qualitative changes in the temperature dependence of
the drug release rate by measuring the amount of drug released as a function of
temperature. The integrated amount of drug released from each of these samples at
different temperatures is shown in Fig. 4.7a. Recalling that the measuring time for
the PNIPAM-SA-Fe3O4 sample is only 4 min compared to 30 min for the PNIPAMSA sample, the release rate for the sample with magnetic nanoparticles is roughly a
factor of 8 larger than for the parent sample. This is reflected in Fig. 4.7b, which
plots the estimated total drug release rate as a function of temperature, assuming a
constant heating rate for both measurements. The higher rate of drug release in Fig
4.7b is important for clinical applications because it will deliver large amount of
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drug in short time scale avoiding longer exposure of alternating magnetic field.
Rather unexpectedly, we do not see any sharp change in the inferred drug release
rate at the LCST for either sample, although there may be a slight anomaly for the
PNIPAM-SA-Fe3O4 sample. This apparent insensitivity of the release rate to the
volume change may arise, at least in part, from electrostatic interactions between
the positively charged secondary amine groups on the mitoxantrone with the
negatively charged carboxylic acid and

Figure 4.7: (a) Integrated fractional drug release (%) as a function of temperature
for mitoxantrone loaded PNIPAM-SA and PNIPAM-SA-Fe3O4. (b) Estimated
integrated drug release rate for mitoxantrone loaded PNIPAM-SA and PNIPAMSA-Fe3O4 as a function of temperature assuming a constant heating rate over 4 min
total for PNIPAM-SA-Fe3O4 and 30 min total for PNIPAM-SA. (c) Structure of
mitoxantrone. Taken from R. Regmi et al ., J. Mater. Chem., 20, 6158 (2010).
sulfonate groups on the microgel. Such electrostatic interactions could obscure
changes in release rate from the conformal effects produced by hyperthermia. As
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shown in Fig. 4.7c, mitoxantrone has two amine groups having dissociation
constants of pKa=5.99 and pKa=8.13 [129]. pKa is -log10Ka, where Ka is the acid
dissociation constant defined as the ratio of the product of concentration of ionized
molecule to the concentration of unionized molecules given in units of mol/L. At the
pH used in these investigations (pH=7.4), the protonation for the amine group is
calculated by using the following relation [130]:

1 
pH  pKa  log
 …………………………………………………….(4.1)
  
Where θ is the degree of protonation. Using equation (4.1), we found the protonation
for amine group having pKa=5.99 and pKa = 8.13 as 3.74 % and84.3 % respectively .
This will lead to an overall positive charge at physiological pH. Conversely, we ﬁnd
a zeta potential of -21.6 mV for the bare PNIPAM–SA polymer, which drops to -13.9
mV with the incorporation of Fe3O4 nanoparticles, consistent with a positive charge
on the nanoparticles themselves. This zeta potential increases to -33.8 mV with the
addition of sodium polystyrene sulfonate used to improve the colloidal stability,
providing the negative charge to compensate the positive mitoxantrone molecules.
Alexiou et al. [131] have also discussed ionic binding between cationic mitoxantrone
and anionic ferroﬂuid. It could be possible to mitigate these electrostatic
interactions by selecting a more suitable drug or developing a technique to
covalently embed the magnetic nanoparticles in the microgel to allow a reduction of
the sodium acrylate monomer content. While these electrostatic effects are expected
to provide the dominant mechanism for controlling the drug release in these
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composites, other interactions may also play a role and should be considered in
future studies. A similar weak dependence of drug release on sample volume was
observed in studies on doxorubicin loaded in PNIPAM [120]. Coughlan et al. [106]
have also shown that drug release from the PNIPAM hydrogel depends on the
solubility and chemical nature of drugs. The drug release rate from our PNIPAMSA-Fe3O4 samples (1 %/min average over this temperature range) is about three
times larger than that found by Purushotham et al. [120] (0.31 %/min), although the
release rate from our PNIPAM-SA samples is smaller. Because the magnetic
heating in the PNIPAM-SA-Fe3O4 composite is much faster than the water bath
heating for PNIPAM-SA, the rate of drug release from the magnetic microgel is
much faster than the rate of release from the parent sample. As the efficacy of
mitoxantrone is improved at elevated temperatures [132], we speculate that in
addition to providing for controlled release, the thermal effects arising from
magnetic heating may also contribute to improved outcomes for therapies based on
this PNIPAM-SA-Fe3O4 composite system.

4.2.3 CONCLUSIONS
We were able to successfully combine Fe 3O4 nanoparticles with PNIPAM
polymer to produce a magnetic microgel composite, which exhibits a conformal
transition at an LCST of approximately 311 K. The composites have a relatively
high saturation magnetization, on the order of 33 emu/g, allowing for magnetic
heating. The magnetic microgels can be heated to temperatures above the LCST
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with the application of an external alternating magnetic field for only a few
minutes.

We investigated the loading and release of the anti-cancer drug

mitoxantrone into the PNIPAM-SA-Fe3O4 composite and into the parent PNIPAMSA composite. Interestingly, the drug upload fraction was larger (100 %) for the
magnetic microgel than for the non-magnetic PNIPAM-SA parent composite (65 %) ,
and the estimated release rate was much higher, being approximately a factor of 8
larger. Although the drug release does not appear to be particularly sensitive to the
LCST transition in the PNIPAM-SA-Fe3O4 microgel, this system offers the
possibility of combining the functionality of magnetic nanoparticles with the
polymer matrix to allow controlled drug release using only non-invasive magnetic
fields in a short interval of time.

4.3

DRUG RELEASE FROM DEXTRAN COATED IRON

OXIDE
Motivated by the success in using the PNIPAM/Fe 3O4 polymer/nanoparticles
composites from drug loading and hyperthermia controlled release, we extended
these investigations to other systems. Since dextran coated nanoparticles can evade
RES system and can circulate inside body, drug release from dextran coated iron
oxide nanoparticles is of great interest. Saboktakin et al. [133] has studied release
of a model drug 5- aminosalicyclic acid from 70 kDa amine functionalzied dextran
coated iron oxide nanoparticles and found a release of about 85 % in about 15 h.
Babincova et. al. [134] observed substantial release of 6-carboxyfluorescein dye
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triggered by laser from dextran-Fe3O4 encapsulated liposomes. In addition,
Perlstein et. al. [135] have shown the possibility of drug delivery into the brain by
using 35 to 45 kDa dextran coated iron oxide nanoparticles. In this context, we did
the drug release study from different chain length dextran (15-20 kDa and 60-90
kDa) coated iron oxide nanoparticles to investigate whether the different chain
length of dextran controls the drug release or not.
We synthesized iron oxide nanoparticles coated with 15-20 kDa and 60-90
kDa molecular mass dextran as described in section 2.1.3. An anticancer drug,
camptothecin, was loaded by a solvent evaporation method. 1 mg of camptothecin
was loaded in each of the two samples with a loading efficiency was 100 %. The drug
release into PBS was monitored as a function of time using a Cary 50 Bio UV-
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Figure 4.8: Drug release from 15-20 kDa and 60-90 kDa dextran coated sample.
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The drug release profile for these two different samples is shown in Fig 4.8. The
integrated fractional drug release from the 15-20 kDa and 60-90 kDa dextran

Drug Release (%)

coated nanoparticles samples was 8 and 12 % respectively in 72 h. At short time,
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Figure 4.9: Fit of equation (1) to the drug release of (a) 15-20 kDa dextran coated
sample and (b) 60-90 kDa dextran coated sample.
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when the concentration of drug in the composite is highest, the release rate is large,
while as the drug leaves the composite, the rate is reduced. These release profiles
can be fit to an exponential relaxation, with different characteristic relaxation times
for the two molecular masses as:
Drug release = A o (1-e-t/τ)……………………………..(4.2)
Where Ao is saturation value of drug release and τ is the time constant for drug
release. The fits to Eq. (4.2) for the 15-20 kDa dextran and 60-90 kDa dextran is
shown in Figs. 4.9a and b respectively.
The value of Ao is near 7.5 and 12 % for 15-20 and 60-90 kDa dextran coated iron
oxide respectively, which have relaxation times are close to 19 and 24.5 hrs. There
are a number of factors that could influence the release rate from the composite.
The number of binding sites for the drug to the polymer likely varies with chain
length. Since the longer chain dextran has more sites, and these will be located
further from the magnetic nanoparticle on average, we expect the asymptotic drug
fraction released should be larger, as observed experimentally. However, we also
expect that the diffusion rate for the drug through the polymer coating may be
smaller for the high molecular mass dextran as compared to the lower mass
dextran, leading to a larger time constant. Further studies will be required to
properly determine the rate-limiting step responsible for drug release from dextran
coated iron oxide nanoparticles.
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To conclude, we studied drug release from different chain length dextran
coated iron oxide nanoparticles and found higher drug release from longer chain
length dextran coated samples. This offers an exciting possibility for controlled drug
release from different chain length dextran coated nanoparticles, since the time
constant for the release may be tuned by dextran mass, and also allows the
possibility of engineering a very flat release rate by combining different molecular
mass dextrans together.

4.4 CELL NUCLEUS TARGETING
While these previous studies of functionalized iron oxide nanoparticles in
solution offer important insight into their physical properties, it is necessary to
understand the interactions of these nanoparticles with living cells. As a first step
in confirming that these nanoparticles may be viable for biomedical applications, we
confirmed that they are non-toxic in sufficiently small quantities.
Having confirmed that these iron oxide nanoparticles are non-toxic, at least
in sufficiently small concentrations, the next step was to determine whether the
nanoparticles are able to penetrate into the cell. More specifically, many
applications, including brachytherapy and transfection, require the nanoparticles to
localize at the cell nucleus. For example, Polyakov et al. [136] has localized toxic
radioisotope at the cell nucleus to improve radiotherapy. Snyder et al. [137] has
used tat peptide for the enhanced delivery of therapeutic DNA into cell nucleus.
Since tat peptide is known to target cell nucleus [136,137], we labeled dextran
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coated iron oxide nanoparticles with tat peptide as described in section 2.1.4. The
specific aim of this study is to localize iron oxide nanoparticles near the cell nucleus
to enhance the effects of radiation brachytherapy treatment. Since glioblastoma
multiforme (GBM) tumors show limited response to current therapies, our goal is to
introduce iron oxide nanoparticles to the GBM cell nucleus, which will down-convert
penetrating high energy x-rays to more damaging, lower energy radiation to kill the
cancerous cells. As a first step in this project, we have conducted in vitro studies to
target the nucleus of human glioblastoma cells by tat conjugated iron oxide
nanoparticles.

Figure 4.10: Time dependent study of Tat peptide labeled iron oxide nanoparticles
penetrating cell nucleus.
We labeled tat counjugated iron oxide nanoparticles by fluoro isothicyanate (FITC)
dye, which makes the nanoparticles visible in fluorescent imaging. To confirm that
the iron oxide nanoparticles are reaching the cell nucleus, we stained the cell
nucleus with blue colored DAPI and the cytoplasm by red phalloidin-TRITC. Figure
4.10 shows overlapping confocal microscopy images of green and blued (green +
blue = cyan) 24 h after the injection, 48 h after injection, and 72 h after injection.
These images establish that the iron oxide nanoparticles are mainly localized at the
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cell nucleus, although there are residual nanoparticles in the surrounding
cytoplasm. Maximum nanoparticles concentration at the cell nucleus occurs after
48 h. Since the green FITC dye was attached to the dextran coating, and not
directly to the iron oxide nanoparticle , we also did a Prussian blue staining to map
the iron distribution, as shown in Fig. 4.11. These images confirm that the iron
oxide nanoparticles have reached the cell nucleus, eliminating the possibility that
the dextran could have separated from the nanoparticles during the process.

(a)

(b)

Figure 4.11: Prussian blue staining of (a) control glioblastoma cells without tat
conjugated nanoparticls (b) glioblastoma cells with nanoparticles.
We see in Fig 4.11 that the control glioblastoma cells (left panel) do not show any
signature after Prussian blue staining whereas the cells with tat conjugated
nanoparticles (right panel) do show a clear blue staining inside the cell nucleus. We
also did magnetic measurements on the cells using a SQUID magnetometer to
quantify the iron oxide nanoparticles concentration inside the cell nucleus. The
M(H) curve is shown in Fig 4.12. We have done the background subtraction in the
M(H) of Fig 4.12. The saturation of the curve indicated the presence of
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superparamagnetic iron oxide

nanoparticles. Given that these iron oxide

nanoparticles have a saturation magnetization of 60 emu/g, we calculated the
number of iron oxide nanoparticles per cell from the saturation magnetization in
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Figure 4.12: M(H) curve of human glioblastoma cells with iron oxide nanoparticles.
Fig. 4.12. The number of iron oxide nanoparticles per cell is close to 6 x 10 6, which is
equivalent to 21 picogram of iron oxide per cell. It is important to know this value of
the concentration in order to estimate the efficacy of using these nanoparticles to
improve the outcomes for radiation brachytherapy. It is also crucial to have the
right concentration of iron oxide into cell to avoid the toxicity due to iron oxide
itself. We had done a cytoxicity study and had found the concentration 21 picogram
iron oxide per cell is not toxic to cell. We had also done a separate study where we
found 250 nanogram of iron oxide per cell was not toxic whereas concentrations
above it were toxic to cells.
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In conclusion, we successfully synthesized iron oxide nanoparticles labeled
with tat peptide. Our preliminary studies also show, tat peptide has taken these
nanoparticles to the nucleus of the cell and the internalization of iron oxide
nanoparticles is highest after the incubation period of 48 h. We also confirmed the
presence of iron oxide nanoparticles inside cells using magnetic measurement,
which also help us to quantify the amount of iron oxide nanoparticles inside cells.

4.5 SUMMARY
We did the magnetic hyperthermia triggered in vitro drug release study.
Drug release rate of mitoxantrone loaded into the magnetic thermosensitive
polymer PNIPAM in the presence of alternating magnetic field of 70 Oe is 8 times
larger compared to bare PNIPAM using water bath. This allows a short time
exposure of an alternating magnetic field to get higher amount of drug release. We
also did the camptothecin drug release from 15-20 kDa and 60 -90 kDa dextran
coated sample as a function to time. We found higher drug release from higher
molecular weight dextran coated sample.
We successfully synthesized the tat peptide labeled dextran coated iron oxide
nanoparticles. In vitro studies suggest that these tat conjugated nanoparticles have
penetrated the nucleus of the human glioblastoma cells, which has a great potential
for the localized radiation therapy.
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Chapter 5
MAGNETIC AND DIELECTRIC PROPERTIES OF
NANOPARTICLES
5.1 INTRODUCTION
Nanocrystalline materials have high surface to volume ratios and can show
properties different from their bulk counterparts. Bulk magnetic materials are
comprised of a number of different domains. Spins in each domain are aligned in
same direction, with these domains separated by walls having more complex spin
arrangements. In single domain magnetic nanoparticles, behaviors arising from
domain walls are absent, which gives different magnetic and electric properties
than bulk materials. Since magnetic nanoparticles have many applications,
including magnetic sensors and transducers, microwave adsorption, electromagnetic
wave shielding, and high density information storage [138], it is of great interest to
investigate the dielectric and magnetic properties of these systems. In addition,
coating nanoparticles with surfactants and dispersing them in carrier liquids,
producing a ferrofluid, offers the possibility of producing new functionalities.
Dielectric studies of these ferrofluids can also give information about stability,
homogeneity and structure of the particles in solution [139]. Magnetic measurement
on these ferrofluids can provide information on the magnetization and dynamics of
nanoparticles embedded in polymers. Finally, it has also been observed that
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dielectric anomalies may accompany magnetic transitions [140], so dielectric studies
of nanoparticles may allow additional insight into their magnetic properties.
Many widely studied magnetic nanoparticles are spinel oxides, which can be
represented by the general form of AB 2O4, with A and B representing the
tetrahedral and octahedral sites respectively in the spinel lattice. These materials
are attractive systems for the study of complex magnetic order. Both the tetrahedral
A site ions and the octahedral B site ions can be magnetic, which, in combination
with the fact that the B site ions sit on a pyrochlore lattice, leads to the opportunity
to investigate a wide range of complex magnetic behaviors in spinels [141,142]. The
magnetic and electric properties of these spinel oxides also depend on the choice and
distribution of cations between the A and B sites. We have studied the magnetic
and dielectric properties of bare Mn 3O4 and dextran coated iron oxide nanoparticles.

5.2 SUPPRESSION OF LOW TEMPERATURE MAGNETIC
STATES IN Mn3 O4 NANOPARTICLES
The complex magnetic structures arising in Mn 3O4, ideally having Mn 2+ at
the A sites and Mn3+ at the B sites, have been discussed theoretically [142-144],
and studied experimentally [145-147]. Bulk Mn3O4 exhibits a tetragonal JahnTeller distortion at the Mn 3+ site at high temperatures to the I4 1/amd space group,
and orders ferrimagnetically into a Yafet-Kittel phase at T N=42 K. At lower
temperatures, Mn3O4 undergoes a transition to an incommensurate phase at 40 K
and a transition to a commensurate phase at 34 K, which is cell doubled relative to
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the Yafet-Kittel phase. Recently, the magnetodielectric response in Mn 3 O4 has been
investigated in both ceramic [148] and single crystal samples [149], where it is
observed that dielectric anomalies accompany the magnetic transitions.
The suppression of magnetic ordering transitions in finite size systems has
been studied theoretically and experimentally. The magnetic ordering temperature
is predicted to vary with the system size according to [150]:


TN ()  TN (d )   0 
   ………………………………….(5.1)
TN ()
d

with TN() and TN(d) the bulk and nanoscale magnetic ordering temperatures
respectively,  0 the T=0 correlation length. λ is the exponent for finite size scaling,
related to the critical exponent ν, which is expected to vary from λ=1 for mean field
transitions [151] to λ=2 for Ising spins [152]. This relation has been experimentally
confirmed in a number of antiferromagnets, including CoO [150] and Cr [153] films
and Co3O4 nanoparticles [154].
Studies on other nanoscale magnetic materials have established that
magnetic structures can be completely suppressed in nanoparticles, for example, the
helical antiferromagnetic order developing in bulk FeP appears to be absent in FeP
nanoparticles [155]. Mn 3O4 is a particularly attractive system for the study of finite
size effect on magnetic transition temperature, because it exhibits three distinct
magnetic transitions. Although there have been several studies on nanomaterials
incorporating Mn3O4, many of these have involved composite systems, such as
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Mn/Mn3O4 [156] or MnO/Mn3O4 [157] core-shell nanoparticles, and focused on the
ferrimagnetic transition on Mn3O4, which is found to be at most slightly suppressed
in finite size systems [158]. Within this framework, we have carefully studied the
magnetic

and

thermodynamic

properties

of

Mn 3O4

nanoparticles

at

low

temperatures to investigate whether the transition temperature of the other two
magnetic phases show additional suppression

compared to

the

onset of

ferrimagnetic order.

5.2.1 EXPERIMENTAL DETAILS
We used a co-precipitation method to synthesize Mn 3O4 nanoparticles as
described in section 2.1.10. We collected X-ray diffraction patterns using Cu Kα
radiation on a Rigaku Ru2000 rotating anode diffractometer to confirm the
crystalline structure of the nanoparticles. Raman spectra were taken at room
temperature using a Ar+-ion laser (514.5 nm) with a Triax 550 detector. AC and DC
magnetization, and specific heat capacity measurement were taken using standard
options on a Quantum Design Physical Property Measurement System (PPMS). For
AC magnetization measurement, we packed about 20 mg of nanoparticles in a
gelatin capsule and compressed with cotton to avoid the motion of the nanoparticles
during measurement. For the specific heat capacity measurement, we mixed 60 mg
of Mn3O4 nanoparticles with silver powder in 1:1 ration by weight and cold pressed
into a solid pellet to ensure a good thermal contact.
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5.2.2 RESULTS AND DISCUSSIONS
X-ray diffraction patterns are shown in Fig 5.1a and all the peaks can be labeled to
the crystalline structure of Mn 3O4. This implies that no impurity phases are present
in these samples. We estimated the size of nanoparticles to be 15 nm using the
Debye-Scherrer equation d=0.9λ/βcosθ, where β is full width half maximum
(FWHM) of the peak. TEM images of Mn3 O4 nanoparticles are shown in Fig 5.1c.
These show some agglomeration and the nanoparticles are not uniformly spherical.
The average diameter of these nanoparticles is 25 nm with a standard deviation of
approximately 4 nm. The size of these nanoparticles determined from TEM images
is greater than that found from XRD because of the amorphous surface layer on the
particles. We also took Raman spectra for these Mn 3O4 nanoparticles (compressed
into a pellet) at room temperature. We found the same peaks observed as in bulk
Mn3O4 with some redshift and broadening of the peaks, again confirming the phase
purity of these Mn3O4 nanoparticles. Room temperature Raman spectra for
nanoparticles and bulk Mn 3O4 are shown in Fig. 5.1b. The high intensity peak at
654 cm-1 in bulk Mn3O4 is shifted to 640 cm-1 in Mn3O4 nanoparticles. Similarly, the
low intensity peaks at 365 cm-1 , 313 cm-1 and 278 cm-1 in bulk Mn3O4 are shifted to
350 cm-1 , 295 cm-1, and 272 cm-1 respectively in the Mn 3O4 nanoparticles. Han et al.
have also reported similar redshifts for Mn3O4 nanoparticles prepared in
mesoporous silica [159]. We did zero field cooled (ZFC) and FC (field cooled)
measurements at a field of 1 kOe. These ZFC and FC curves are shown in Fig. 5.2.
The ZFC curve shows a peak at 40 K and a ferri magnetic transition at 42 K with a
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sharp rise in magnetization. We confirmed the ferrimagnetic transition falls
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between 42 and 43 K from an Arrot plot, as shown in the inset of Fig 5.2. The
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Figure 5.1: (a) X-ray diffraction spectrum for Mn 3O4 nanoparticles (b) Raman
spectra for bulk and nanoparticle Mn 3 O4. Inset: Magnified peaks of lower wave
number (c) TEM images of Mn 3 O4 nanoparticles. Taken from J. Magn. Magn.
Mater., 321, 2296 (2009).
ferrimagnetic transition has been observed in bulk Mn 3O4 at 42 K [148]. The peak
at 40 K is likely related to superparamagnetic blocking in the Mn 3O4 nanoparticles;
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this feature is not observed in bulk Mn 3O4 [148]. However, bulk Mn 3O4 does exhibit
a splitting of ZFC and FC curve [148], but this may be associated with the
incommensurate magnetic transition. Moreover, the rounded peak in the ZFC curve
in the Mn3O4 nanoparticles, which was not observed in bulk Mn 3O4, is consistent
with the polydispersity of the nanoparticles. The saturation magnetization shown
by FC curve in Mn3O4 nanoparticles is one third of that in bulk Mn 3 O4.
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Figure 5.2: Zero field cooled (ZFC) and Field cooled (FC) magnetization curves for
Mn3O4 nanoparticles measured at 1000 Oe. Inset: Arrot plot showing ferrimagnetic
transition between 42 and 43 K.
This decrease in magnetization is likely due to the presence of disordered surface
spins in magnetic nanoparticles [160,161]. Most significantly, we do not observe any
other magnetic transition between 10 K and 42 K in Mn 3O4 nanoparticles, while
bulk samples are known to show other ordering transitions at 34 and 40 K [148].
We also measure the AC susceptibility as a function of temperature at 1 and
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Figure 5.3: (a) Real and (b) imaginary ac susceptibility of the Mn 3O4 nanoparticles
measured at f=1 kHz and f=10 kHz. The arrow indicates the onset of the frequency
dependent magnetic response we associate with surface spins.
10 kHz. Figs. 5.3 a and b show the real and imaginary parts of the AC susceptibility
as a function of temperature at different frequencies. Both the real and imaginary
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part of the AC susceptibility show peaks at 42 K corresponding to the Yafet-Kittel
magnetic ordering transition. The in-phase component of AC susceptibility does not
show a signature for any other magnetic transition from 15 K to 42 K. However, the
out-of-phase component shows some anomaly near 30 K, below the cell doubled
phase transition seen in bulk at 33 K [148]. This anomaly may instead be due to the
freezing of surface spins in magnetic nanoparticles, which have been also reported
in the literature for a number of different magnetic nanoparticles system [162,163].
We also measured the heat capacity measurement from 25 K to 50 K, which
is plotted in Fig. 5.4. This heat capacity measurement shows a thermodynamic
phase transition at 42 K corresponding to ferrimagnetic Yafet-Kittel ordering.
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Figure 5.4: Specific heat plotted as a function of temperature for the Mn 3O4
nanoparticle sample.
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with the AC susceptibility measurements. The entropy associated with the
magnetic ordering of the Mn 3O4 nanoparticles is one half as large as that of bulk
Mn3O4. This is roughly consistent with the reduction of the net magnetic moment by
a factor of one third in nanoparticles as compared to bulk Mn 3O4. This implies that
there is a layer of spins that do not order magnetically at the Néel temperature but
remain as an amorphous surface spin layer.
All these difference measurements suggest that the Mn 3O4 nanoparticles
have only the single ferrimagnetic Yafet-Kittel phase transition near 42 K, which is
within the few percent of transition temperature observed in bulk Mn 3O4. However,
other two transitions observed in bulk Mn 3O4 below 42 K are absent in
nanoparticles. This may be partially because of finite size effect. The wavelength of
the incommensurate magnetic structure exceeds tens of chemical unit cells, which is
longer than 10-20 nm in case of Mn 3O4 nanoparticles. Since the wavelength of
incommensurate magnetic structure is larger than the magnetic size of the Mn3O4
nanoparticles, 15 nm, this incommensurate phase might not develop in these
nanoparticles. The cell doubled phase, which develops below 34 K in bulk Mn 3O4,
has a c-axis of length 8 nm, which is about half the size of the Mn 3O4 nanoparticles.
While there is a possibility that these two low temperature magnetic transitions
might be suppressed by finite size effects, there could be also other mechanisms
responsible. Equation (5.1) parameterizes the suppression of magnetic transitions
due to finite size effects. For the cell double phase, the magnetic transition
temperature has been suppressed by much more than the factor of two. Using
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equation (5.1), with ξ0 approximately equal to the wavelength of the magnetic
structure, we found a scaling exponent λ>4, which has no existing explanation.
Therefore, we also propose that surface spins in Mn 3O4 nanoparticles may also
contribute to the suppression of the cell doubled magnetic transition in Mn 3O4
nanoparticles.
These thermodynamic and magnetic measurements suggest that 30 % to 50
% of the Mn spins do not contribute to ordering at the ferrimangetic transition.
Local interaction with

amorphous surface spins may play a large role in the

suppression of lower temperature magnetic transitions as compared to finite size
effect. These surface spins might have a smaller effect on the ferrimagnetic
transition since the transition is above the blocking temperature of Mn 3O4
nanoparticles (Fig. 5.2) and the spins are fluctuating in paramagnetic phase. Below
Yafet-Kittel transition, the surface spins starts freezing as indicated by Fig 5.3b.
These freezing surface spins produce static random field, which might have
provided the additional barrier to present the low temperature magnetic transition
in Mn3O4 nanoparticles.

5.2.3

CONCLUSIONS
In Mn3O4 nanoparticles, the Yafet-Kittel phase transition is present while

the incommensurate and cell doubled phase transition observed in bulk Mn 3O4 are
absent above at least 15 K. Both thermodynamic and magnetic measurements show
the presence of a Yafet-Kittel transition and the suppression of other two
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transitions. We also observed superparamagnetic blocking and surface spin freezing
based on DC and AC magnetization respectively. We propose that the suppression
of the low temperature magnetic transitions in Mn 3O4 nanoparticles is due to
disordered surface spins in addition to finite size effect.

5.3 DIELECTRIC MEASUREMENTS ON FERROFLUID
Considering the dielectric response, ferrofluids should be considered as a
heterogeneous dielectric mixture consisting of magnetic nanoparticles coated with
charged surfactant and dispersed in dielectric liquid. This allows several dielectric
relaxation processes in this complex fluid. The distribution of counter-ions around
the particles in the presence of electric field leads to the polarization of particles,
which is responsible for low frequency dielectric relaxation [113]. At high
frequencies and low temperature, an interfacial relaxation process occurs because
the mobility of ions around the particles is insufficiently rapid to follow the change
in electric fields [164]. Additional contributions to the dielectric response of
ferrofluids come from relaxation in the carrier liquid and from the intrinsic
properties of the magnetic nanoparticles comprising the ferrofluid. Dielectric
studies

on

ferrofluid

provide

information

about

the

structure,

stability,

homogeneity, and dielectric relaxation processes in the system [139]. Dielectric
measurement while applying a magnetic field on ferrofluid can yield insight into the
correlation between the dielectric behavior and pattern formation in the ferrofluid.
Since magnetic nanoparticles in solution form chains under an applied magnetic
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field, magnetic fields can change dielectric behavior of a ferrofluid. This can allow
one to indirectly probe the distribution of nanoparticles in a ferrofluid under an
applied magnetic field by measuring the dielectric behavior. In general, a change in
dielectric behavior with an applied magnetic field is referred as a magneto-dielectric
effect, and, in ferrofluids, these properties have generally only investigated only
near or above room temperature. Malaescu et al. [165] has used dielectric
spectroscopy of magnetite nanoparticles dispersed in kerosene to analyze the
presence of particle agglomeration inside a ferrofluid. Nasri et al. [139] has
observed magneto-dielectric anisotropy after applying continuous magnetic field on
manganese ferrite based ferrofluid. We have studied the dielectric behavior of
dextran coated Fe3O4 dispersed in 0.5 M NaOH as function of temperature,
frequency, and applied magnetic field to investigate field -induced changes in the
nanoparticles distribution and magnetodielectric coupling in the ferrofluid.

5.3.1 EXPERIMENTAL DETAILS
We synthesized dextran coated Fe 3O4 nanoparticles that were dispersed in
0.5 M NaOH as described in the section 2.1.3. For the dielectric measurement,
which required the ferrofluid be loaded into vacuum tight cell capable of
withstanding low temperatures, we designed a custom dielectric cell. This brass cell
is cylindrical with a diameter of ~ 18.5 mm (0.730”) and a height of 10.6 mm (0.42”).
It is fabricated from separate upper and a lower halves to allow the dielectric liquid
to be loaded. Each half contains a circular conducting plate used an electrode, which
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is electrically isolated from the rest of the cell by insulating black epoxy (Stycast
2850). An indium O-ring, which maintains its integrity at very low temperatures, is
to seal the cell. Black epoxy was also used to make vacuum tight electrical
feedthroughs to the electrodes. The spacing between the capacitor plates was
adjusted to be ~ 1.5 mm when the cell is closed. The interior volume available for
the ferrofluid of roughly ~ 30 mm3.. This cell can be mounted in a Quantum Design
PPMS, which provides temperature and magnetic field control. A schematic
diagram of the cell is shown in Figs 5.5 and 5.6.

5.3.2 RESULTS AND DISCUSSIONS
We measured the dielectric response of dextran coated Fe 3O4 ferrofluid in
this dielectric cell over a temperature range from 10 K to 300 K. At lower
temperature, we observe a frequency dependent peak in the dielectric loss as shown
in Fig. 5.7 a.
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Figure 5.7: Dielectric loss as a function of temperature at different frequency in
dextran-Fe3O4 ferrofluid (a) from 30 to 80 K and (b) from 100 to 175 K.
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We fitted the temperature and frequency dependence of this peak to an Arrhenius
equation, shown in Fig 5.7 a, and found an activation energy of 56 meV. We also
observed a second frequency dependent peak near 125 K, shown in Fig 5.7 b. To
confirm that the lower temperature peak is associated with some relaxation
mechanism of the nanoparticles in solution, we also measured the AC susceptibility
of this dextran Fe3O4 ferrofluid and conducted dielectric measurement on a pellet
pressed from the residue of the freeze-dried ferrofluid. Neither of these
measurements showed any frequency dependent peak near 125 K, suggesting that
this higher temperature peak may an extrinsic artifact associated with a resonance
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Figure 5.8: AC loss as a function of temperature at different frequency in dextranFe3O4 ferrofluid.
in the dielectric probe. However, these measurements confirm that the peaks
observed at lower temperatures in the dielectric measurement, near 40 K, can be
associated with magnetic relaxation of nanoparticles, as seen Fig. 5.8.
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Furthermore, the fact that a sharp peak in the dielectric relaxation can be seen in
the solid sample at the same temperature, as shown in Fig. 5.9, implies that this
anomaly is a single-particle effect, and does not arise from any property of the
nanoparticles in solution. We estimate the activation energy for the magnetic
relaxation by fitting an Arrhenius equation to the frequency dependent peaks
observed in AC susceptibility measurement of dextran-Fe3O4 ferrofluid.
yielded

This

a value of 51 meV, which is consistent with the activation energy we

obtained from dielectric measurement. This confirms that the same underlying
mechanism is responsible for both features. The presence of coincident anomalies in
both dielectric and magnetic measurements also confirms the presence of magneto-

D (Dimension less)

dielectric coupling in these iron oxide nanoparticles.
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Figure 5.9: Dielectric loss as a function of temperature in dextran-Fe3O4 pellet.
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In order to investigate the effects of chain formation on the dielectric response of the
ferrofluid, we also measured the dielectric response by sweeping the frequency at
different temperatures and magnetic field We plot the dielectric loss as a function
of frequency normalized to the maximum value for these different measurements in
Fig 5.10, where (0T, 0T) represents the sample was cooled at 0T and the
measurement was also done at 0 T and (2T, 0T) represents the sample was cooled at
2 T and the measurement was done at 0 T. The reason for cooling the sample at
applied field and zero filed was nanoparticles will form more chain like structure in
the presence of applied magnetic field and will show different dielectric behavior
than that of zero field cooled. Data in Fig 5.10 are generally analyzed in terms of
the Casimir-du Pré relation with single relaxation time [166]. Since the relaxation
curves at different temperature and magnetic fields coincide, as shown in Fig 5.10,
the characteristic relaxation behaviour is identical. In particular, this analysis
suggests that the formation of nanoparticles chains has no significant effect on the
relaxation. We also investigated the dielectric response of the ferrofluid at the
melting transition at fields of 0 T, 2 T and 5 T to study the effects of chain
formation. These results are plotted in Fig 5.11 a, with Fig 5.11 b showing the
difference between the high field and zero field data. Again, all the measurements
were done at 0 T whereas sample was cooled at 0 T, 2 T, and 5 T as indicated in the
legend of Fig 5.11 to investigate chain formation in ferrofluid. The sharp increase in
dielectric loss on melting is associated with a dramatic increase in conductivity in
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Figure 5.10: Dielectric loss as a function logarithm of frequency scaled to their
maximum value at different temperature.
the liquid phase since the ferrofluid is only a good dielectric in the frozen state when
electrical conductivity is suppressed. However, we didn‟t see any noticeable
signature of chain formation from these data.
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Figure 5.11: (a) Dielectric loss as a function of temperature at 0 T, 2 T and 5 T. (b)
Difference in dielectric loss at 0 T, 2 T and 5 T as a function of temperature.
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Measurements of the electrical properties of the ferrofluid on sweeping
temperature can also yield information about the freezing and melting dynamics in
this system. We measured the zero-field impedance as a function of temperature
while warming and cooling through the phase transition at several different
frequencies. The plots are shown in Fig 5.12. It shows that area of the loop at lower
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Figure 5.12: Impedance as a function of temperature while cooling and warming
ferrofluid.
frequency is higher indicating more dielectric loss at lower frequency as compared
higher one.

5.3.3 CONCLUSIONS
In summary, we designed a vacuum tight dielectric cell to do temperature
dependent dielectric measurements on ferrofluids. Dielectric measurements at
lower temperature showed relaxation peaks near 40 K consistent with AC
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susceptibility measurement, which indicates the presence of magneto-dielectric
coupling in this system. We also did zero field cooled and field cooled dielectric
measurement to investigate chain formation in ferrofluid. However, we couldn‟t see
any signature of chain formation from dielectric measurement. Frequency
dependent study at different temperature implies iron oxide nanoparticles are
monodispersed with single relaxation time. We also observed frequency dependent
dielectric loss from the temperature sweep dielectric measurement at melting
transition of ferrofluid.

5.4 SUMMARY
We investigated suppression of low temperature magnetic states in Mn 3O4
nanoparticles. Only Yafet-Kittel phase transition at 42 K has been observed in
Mn3O4 nanoparticles as compared to three different transition observed at 42 K, 40
K, and 34 K in bulk Mn 3O4. Finite size effect and disordered surface spins might
have suppressed low temperature magnetic states in Mn3O4 nanoparticles. We also
studied the magnetic and dielectric properties of ferrofluid. We observed both
dielectric and magnetic loss peak around 40 K in ferrofluid indicating same
mechanism responsible for the feature, which also indicates magnetodielectric
coupling in ferrofluid. We also did zero field and field cooled dielectric measurement
in ferrofluid to investigate any signature of chain formation in ferrofluid but could
see any noticeable feature regarding chain formation from these measurement. Zero

132

field impedance measurement on ferrofluid around melting transition shows higher
loss at lower frequency.
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Chapter 6
MAGNETIC CHARACTERIZATION OF NiMH
BATTERY
6.1 INTRODUCTION
The transition from hydrocarbon based energy will require significant
advances in energy storage. While there are a number of different technologies on
the horizon, nickel metal hydride (NiMH) rechargeable represent a widely used and
well established energy storage system. These batteries include a hydrogenabsorbing alloy as the negative electrode and nickel oxyhydroxide (NiOOH) as the
positive electrode. These batteries are built on the fact that some metallic alloys
form hydrides by absorbing a volume of hydrogen a factor of one thousand larger
than their own [167]. This produces very high energy storage densities. In addition,
these batteries can be cycled (charged and discharged) hundreds of times making
them a viable long-term solution for energy storage. The charging and discharging
scheme of these batteries is as follows:
Alloy + H2O + e-

Alloy(H) + OH- ………………………………… (6.1)

While charging (the forward reaction in equation 6.1) with an electric potential
applied, the water in the electrolyte decomposes and gives hydrogen ions, which in
turn are absorbed by the alloy at the negative electrode. While discharging (the
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reverse reaction in equation 6.1), the hydrogen desorbs from the alloy and combines
with hydroxyl ions to form water. This process also contribute an electron to the
circuit. The properties of these batteries can be improved by judicious selection of
the electrode materials.. Some commonly used alloys are AB 2, AB 5 and A 2B 7. AB 2
alloys contain metals like titanium (Ti), zirconium (Zr) or hafnium (Hf) at the A site
and transition metals like manganese (Mn), nickel (Ni) or chromium (Cr) at B sites.
The AB 5 alloys contain hydride forming rare earth metal like lanthanum (La),
Cerium (Cr) or Neodymium (Nd) at the A site and non hydride forming metals like
Ni at the B site. A 2B7 is typically based on the La-Mg-Ni system alloy with La and
Mg at A site and Ni at B site.
Although NiMH batteries have a long track record, there remain considerable
opportunities to improve their performance. It is crucial to understand the role of
each element in the electrode through careful study of these alloys, which will give
insight into how to improve their properties. It has been reported that metallic
nickel nanoclusters embedded in the surface oxide of these alloys play an important
role catalyzing the electrochemical reaction in Ni-MH batteries. These Ni based
clusters affect the high-rate dischargeability (HRD) of the electrodes, and increase
corrosion and passivation resistance [168,169]. Magnetic characterization can be
used to help parameterize the surface catalytic activity of alloys since magnetic
measurements give insight into the nanoscale structure of metallic clusters in the
electrodes. In addition, the paramagnetic component of the magnetic susceptibility
can be used to find the concentration of electrons in some alloys [170]. The size of
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the nanoclusters can be obtained by fitting the room temperature magnetization
curves using Langevin function [171]:


H
kT 
M (H )   B H  M s coth(
)
 ………………………………………..(6.2)
kT
H 

where χB is the intrinsic paramagnetic susceptibility of the alloy, which is estimated
by the value of the high ﬁeld magnetization, M S is the saturation magnetization of
the ferromagnetic metallic Ni or Ni-alloy nanoparticles, μ is the net magnetic
moment of each metallic cluster (assuming all the individual Ni spins are locked
together ferromagnetically), k is the Boltzmann constant, and T is the absolute
temperature. The mass fraction of metallic nickel was calculated from the ratio of
the measured MS and the known saturation magnetization of pure nickel metal
(58.6 emu/g) while the size of the metallic nickel clusters was computed using μ
together with the known moment per metallic Ni atom (0.6 μ B/Ni). Within this
framework, we calculated the size of Ni metal clusters and the fraction of Ni in
different sample alloys having applications in NiMH batteries as described below.
In addition, we have also investigated exchange bias effects on these system under
the assumption that the Ni may have oxidized to form Ni-NiO (ferromagneticantiferromagnetic) nanocomposites.

6.2 COBALT SUBSTITUTED AB2 ALLOYS
Cobalt substitution in Ni AB2 alloys has been investigated extensively to
improve hydrogen storage and battery applications. Shaltiel et al. [172] found cobalt
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content decreased the heat formation . Honda et al. [173] found the substitution of
Co for Mn decreased the hydrogen storage capacity whereas Song et al. [174] has
reported increase in capacity by partially replacing Ni with Co. The cycle durability
has also increased by substituting Co as re ported by Chen et al. Same group also
mentioned the increase in heat formation (ΔH) with the increase in Co content.
Similarly, Ji et al. [175] has found that cobalt content has increased cycle stability
and self-discharge. We have done the magnetic studies on the different wt % cobalt
substituted at the expense of Ni and correlated the wt. % of cobalt content as a
function Ni cluster size with performance of battery investigated by other studies on
the same samples.
Co substituted alloys were obtained from Ovonic Battery Company, Rochester Hills,
Michigan. They provided six samples: CA01, CA02, CA03, CA04, CA05, and CA06.
CA01 contains no cobalt, with the Co fraction having a sample-to-sample increase of
0.5 wt % up to sample CA06 with 2.5 wt% of cobalt. The amount of other
constituents including cobalt on these alloys is given in the table 6.1, together with
the Ni fraction and Ni cluster size estimated from the magnetic measurements.
Since the atomic radii and electronegativity of Co and Ni are the same, Co
substitution occurs at the expense of Ni and the overall radii and electronegativity
of the alloys does not change. The magnetic susceptibility of metallic nickel clusters
embedded in the surface layer of the electrodes is several orders of magnitude larger
than from
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Alloy

Ti

Zr

V

Ni

Cr

Mn

Co

Sn

Metallic
Ni (%)

Ni cluster
size (nm)

CA01

12

21.5

10

38.1

4.5

13.6

0

0.3

0.038

10.2

CA02

12

21.5

10

37.6

4.5

13.6

0.5

0.3

0.034

11.5

CA03

12

21.5

10

37.1

4.5

13.6

1

0.3

0.041

9.7

CA04

12

21.5

10

36.6

4.5

13.6

1.5

0.3

0.042

9

CA05

12

21.5

10

36.1

4.5

13.6

2

0.3

0.051

10

CA06

12

21.5

10

35.6

4.5

13.6

2.5

0.3

0.046

10

Table 6.1: Amount of constituents in the arc-melt prepared cobalt doped alloys.
nickel in the alloy due to the availability of unpaired electrons [171], so the amount
of metallic nickel in

this surface can be estimated from magnetization

measurements. These non-destructive magnetic measurements can be done with a
minimum of sample preparation, and measure the average properties over
relatively large volumes, offering considerable advantages over other methods of
probing the Ni nanoparticles concentrations, including TEM. Room temperature
magnetization curves for each of these samples are plotted in Fig. 1. These curves
can be ﬁt to the Langevin function given by equation 6.2.
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Figure 6.1: Room temperature magnetization curves for alloys CA01–CA06.
The Langevin fit depends on the saturation magnetization and net magnetic
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Figure 6.2: Average size and the concentration of metallic nickel cluster as a
function of atomic percentage of Co in alloy.
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of the Ni cluster respectively. These values are given in table 1 and plotted as a
function of cobalt content in Fig 6.2. These investigations established that the
content of metallic nickel increases while the cluster size decrease as Co is
substituted into the alloy. Studies of hydrogen gas storage properties on these
samples show that substitution of Co from 1 to 1.5 wt. % has increased the stability
of hydride and hydrogen storage capability implying the importance of cobalt doping
in higher charge storage [176]. 1.5 % cobalt doping has also lowest metallic Ni
inclusions in the surface oxide.

6.3 ALUMINIUM SUBSTITUTED AB2 ALLOYS
Relatively large size and less number of valence electron in Aluminium
makes it an interesting element to study the substitution effect on NiMH battery.
Inspite of its importance, there are limited number of studies about the Aluminium
substitution in NiMH battery. Gamo and Moriwaki [177] have reported the
reduction in flammability after substituting Aluminium at the expense of Zirconium
(Zr). Wakao et. al. [178] found the durability of electrochemical cycling by the
substitution of Aluminium. Yamamura et al. [179] found the voltage stand at high
temperature has imporved after the substitution of Aluminium in AB2 alloy. We
did magnetic measurements on different wt % Al substituted in AB2 alloy and have
correlated the content of Al with size of Ni cluster to the battery performance
obtained by other studies on the same samples.

140

Aluminium substituted alloys were also obtained from Ovonic Battery
Company, Rochester Hills, Michigan, labeled as: CA01, CA07, CA08, CA09, CA10,
and CA11. CA01 contains no aluminium and the Al fraction increase by 0.2 wt % for
each sample to CA11 with 1 wt% of aluminium. The composition of these alloys,
including information on the Ni content extracted from magnetic measurements, is
given in the table 6.2.
Alloy

Ti

Zr

V

Ni

Cr

Mn

Al

Sn

Metallic
Ni (%)

Ni cluster
size (nm)

CA01

12

21.5

10

38.1

4.5

13.6

0

0.3

0.038

10.2

CA07

12

21.5

10

37.9

4.5

13.6

0.2

0.3

0.059

10.2

CA08

12

21.5

10

37.7

4.5

13.6

0.4

0.3

0.046

9.5

CA09

12

21.5

10

37.5

4.5

13.6

0.6

0.3

0.051

10.3

CA10

12

21.5

10

37.3

4.5

13.6

0.8

0.3

0.057

10.1

CA11

12

21.5

10

37.1

4.5

13.6

1

0.3

0.061

10.1

Table 6.2: Amount of constituents in the arc-melt prepared aluminium doped alloys.
As with the measurements on Co substituted alloys, magnetic measurements can be
used to quantify the amount of metallic nickel on the surface. Room temperature
magnetization curves measured as a function of applied magnetic ﬁeld for these
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samples are plotted in Fig. 6.3. These curves are fit to equation 6.2 to determine the
saturation magnetization and magnetic moment of each nanocluster, which were
then used to calculate the percentage of metallic Ni and size of Ni cluster.
Concentration of metallic Ni and size of Ni cluster for each of the alloy are given in
table 2 and plotted in Fig 6.4. The amount of metallic nickel present shows a sudden
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Figure 6.3: Room temperature magnetization curves for alloys CA01 and CA07–
CA11.
jump as Al is added and then increases steadily with Al fraction, while the average
size of the nickel clusters remains constant at roughly 10 nm. Incorporating Al into
the alloys has increased the number of surface metallic nickel clusters, which
contributes to a high HRD, but does not change the size of Ni clusters. 0.4 %
Aluminium co-substituted with 1.5 % cobalt improves charge retention, high rate
dischargeability, cycle life, specific power, and low temperature performance of
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Figure 6.4: Average size and the concentration of metallic nickel cluster as a
function of atomic percentage of Ni in alloy.
alloy. So, the combination of 1.5 % cobalt and 0.4 % Aluminium is the best
substitution in alloy to improve the quality of the NiMH battery.

6.4 COMPARISONS

OF

METALLIC

CLUSTERS

EMBEDDED IN THE SURFACE OF AB2, AB5, and A2B7
ALLOYS
AB2, AB5 and AB7 are the alloys used in NiMH battery. Careful comparison
of structural and physical properties of these alloys is necessary to identify the
differences between them and suggest the method to improve their properties.
There are a number of open questions concerning the interplay of composition and
catalytic activity, which is strongly affected by Ni nanoclusters, in alloys for NiMH
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battery electrodes. In particular, there is considerable interest in exploring how
chemical etching affects the Ni distribution. In order to measure the size of the Ni
nanoclusters along with the total fraction of metallic Ni, we did magnetic
Alloy

Composition

Alloy

Saturation

Normalized

system

magnetization

cluster size

(memu/g)
A

Ti12Zr21.5Ni36.2V9.5Cr4.5Mn13.6Sn0.3Co2A AB2

33

1

AB5

434

0.93

l0.4
B

La10.5Ce4.3Pr0.5Nd1.4Ni60.0Co12.7Mn5.9Al
4.7

C

La16.3Mg7.0Ni65.1Co11.6

A2B 7

369

1.06

D

Nd18.8Mg2.5Ni65.1Al13.6

A2B 7

132

0.95

Table 6.3: Compositions and summary of Alloys A-D.
measurement on four alloys A, B, C and D described below, prepared with different
etching time: 0 h, 0.5 h, 1h, 2 h, 3 h and 4 h of each. Etching was done at 100 o C in
30 % KOH at above mentioned time intervals to activate the surface of alloys. We
obtained these samples from Ovonic Battery Company, Rochester Hills, Michigan.
The nominal composition and structure are given in the table 3 for these samples.
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Figure 6.5: The magnetic susceptibility curves measured at room temperature for
alloys A (a), B (b), C (c), and D (d).
The characteristics of the nanoscale metallic nickel clu sters embedded in the
surface

oxide

magnetization

were
values

studied by
associated

probing
with

the
the

magnetic susceptibility, The
ferromagnetic

metallic

nickel

nanoclusters is a few orders of magnitude larger than that from the paramagnetic
nickel atoms [171]. Room temperature magnetization curves were measured as a
function of applied magnetic ﬁeld for the etched powder sample. These curves are
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plotted in Fig. 6.5 a–d for alloys A–D, respectively. The saturation magnetization
and magnetic moment of each nanocluster were obtained by fitting equation 6.2
from which the percentage of metallic Ni and size of the Ni clusters were calculated.
For easy comparison, values are normalized to cluster size of 4 h etched Alloy A.
Both the MS values and the normalized sizes of the Ni clusters in the 4 h samples
are listed for each alloy in Table 3 and plotted in Fig. 6.6 a and b. The MS and the
average size of the metallic clusters both decrease with the ﬁrst half-hour of etching
for all four alloys. This suggests a dissolution of the native oxide formed during
powder processing [180]. After this time, a new oxide layer having a higher porosity
due to selective leaching is formed. The thickness of this oxide layer increases with

Figure 6.6: Evolution of the saturated magnetic susceptibility (a), and normalized
cluster size (b) as functions of etching time for alloys A–D. Taken from J. Alloys and

Compd., 506, 831 (2010).
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the etching time until the accumulated hydrogen reduces any further oxidation of
the bulk metal. After 4 h of etching, the magnitude of the saturation magnetization
is largest for Alloy B, followed by the alloy sequence of C, D, and then A. This
implies that the alloy having higher magnetization has high rate dischargeability
associated with metallic nanoclusters but low total capacity which is just opposite in
case of the sample with lowest magnetization.

6.5 SUMMARY
In order to parameterize the size and distribution of Ni nanoclusters in
NiMH

battery

electrode

materials,

we

measured

the

room

temperature

magnetization in cobalt doped and aluminium doped AB 2 alloys. In addition, we also
determined the relative sizes of Ni clusters and saturation magnetization in three
different alloys, namely, AB 2, AB 5, and A 2B7. Sample with higher saturation
magnetization has high rate dischargeability with low capacity and vice versa.
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Chapter 7
SUMMARY
We investigated a number of different properties and biomedical applications
of magnetic nanoparticles. We have focused primarily on biocompatible iron oxide
nanoparticles, which can readily be prepared by a fast, simple, and efficient low
temperature technique. Because of their small size, it is possible to fit millions of
these nanoparticles inside each cell, which we confirmed using magnetic studies.
The surfaces of these nanoparticle can be functionalized by attaching a variety of
biologically active ligands, This offers the possibility of using these particles to
carry biologically and therapeutically relevant molecules inside cells.

By

investigating the physical and biological properties of a variety of these
functionalized iron oxide particles, we have clarified a number of important issues
concerning the biomedical applications of magnetic nanoparticles.
We used a wide range of biocompatible surfactants to coat these
nanoparticles including fatty acids, dextran, and hyaluronic acid. We used different
tools to characterize these nanoparticles, such as Transmission Electron Microscopy
(TEM) to get the core size of nanoparticles, X-ray diffraction (XRD) to confirm the
crystal structure, Dynamic Light Scattering (DLS) and Fluorescent Correlation
Spectroscopy (FCS) to obtain the hydrodynamic size in solution, Thermogravimetry
analysis (TGA) to establish the number of surfactant layers and amount of coating,
Zeta potential studies to find the surface charge, and magnetization measurements
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to establish the magnetic properties of the nanoparticles.

These nanoparticles

synthesis techniques and studies on their fundamental properties provide a strong
platform for continuing investigations on biomedical applications of magnetic
nanoparticles. Some of the specific studies included in this work are investigations
on magnetic hyperthermia, targeted drug delivery and radiation therapy.
We designed and built a magnetic hyperthermia apparatus to investigate the
magnetic heating of these nanocomposites produced by an alternating magnetic
field. This remote heating provides a non-invasive technique for controlling the
nanoparticles properties. In one specific investigation, magnetic heating was used to
trigger the release of an anticancer drug mitoxantrone from a thermosensitive
polymer, poly N-isopropylacryl amide (PNIPAM). We heated PNIPAM-Fe3O4 above
the lower critical solution temperature (LCST) of the nanocompostie, 38 o C, by
applying an alternating magnetic field of 130 Oe for only four minutes. The drug
release rate from PNIPAM-Fe3O4 was 1 % per minute, which is about 8 times larger
as compared to the bare PNIPAM heated using a water bath as a control.
Continuing with the theme of building targeted drug delivery applications around
magnetic nanoparticles, we also studied the dynamics of drug release from
nanoparticles coated by different chain length dextran. An anticancer drug
camptothecin was loaded into 15-20 kDa and 60-90 kDa dextran coated sample and
the loading effieciency was found to be 100 % for both samples. Time dependent
drug release measurements in phosphate buffer saline (PBS) showed 12 % and 8 %
drug release from 60-90 kDa and 15-20 kDa dextran coated sample respectively in

149

72 h implying that higher molecular mass coated iron oxide release more drug as
compared to the lower molecular mass surfactant. As a more discriminating test of
utilizing magnetic nanoparticles for targeted delivery, we labeled these iron oxide
nanoparticles with tat peptide to target the cell nucleus. Our preliminary result
shows that these particles have accumulated inside the cell nucleus, with a net
nanoparticles concentration of approximately 6 x 106 nanoparticles per cell.
Iron oxide nanoparticles have been used for many biomedical application
including MRI, magnetic hyperthermia, targeted drug delivery, magnetofection, and
stem cell tracking but, to best of our knowledge, iron oxide nanoparticles have never
been used for the localized radiation therapy. This novel idea of localizing iron oxide
nanoparticles at the nucleus of the cell to produce higher linear energy transfer
(LET) low enery X-ray and Auger electron to damage cell DNA offers an exciting
opportunity to investigate novel applications of magnetic nanoparticles in radiation
therapy. In addition, since iron oxide acts a contrast agent in MRI, combining iron
oxide based radiation therapy with MRI brings one more promising possibility in
the emerging area of image guided radiation therapy for cancer treatment.
In order to further investigate the properties of magnetic nanoparticles in
solution, we also investigated the dielectric behavior of iron oxide based ferrofluid.
This involved designing and building a vacuum tight dielectric cell capable of
holding to low temperatures. Dielectric studies on iron oxide based ferrofluid
showed relaxation peak at lower temperature of around 40 K, which was also
accompanied by magnetic measurement, implying significant magnetodielectric
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coupling in this system. We have also done field cooled and zero field cooled
dielectric studies on the ferrofluid to investigate the chain formation but did not see
any noticeable feature that could be associated with chain like structures in these
measurements. Beyond studies of iron oxide nanoparticles, we also explored the
properties of other types of magnetic nanoparticles. We established that several low
temperature magnetic transitions are suppressed in Mn 3O4 nanoparticles, plausibly
due to surface spins.

This has important implications for designing nanoscale

devices based on novel magnetic materials, as it suggests that the desirable
magnetic characteristics may not persist in reduced geometries. We also
investigated the magnetic response of different alloys used for NiMH battery
electrodes to explore the size and distribution of Ni nanoparticles in these systems.
These Ni nanoparticles play an important role in catalyzing the electrochemical
reaction and powering the NiMH batteries, so it is important to develop nondestructive techniques for studying these particles. We also extended these studies
to probe the exchange bias effect in this system to indirectly characterize the
properties of a Ni-NiO (ferromagnetic-anitferromagnetic) nanocomposite formed by
the oxidation of the Ni nanoparticles.
In summary, the physical properties of nanoscale magnet, such as size,
biocompatibility, ease of functionalization and the ability to manipulate them using
non-invasive external magnetic field, make them promising agents for biomedical
applications. This thesis has investigated many physical properties of iron oxide
nanoparticles along with many biomedical applications.
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Magnetic nanoparticles have a number of unique properties, making them
promising agents for applications in medicine including magnetically targeted drug
delivery, magnetic hyperthermia, magnetic resonance imaging, and radiation
therapy. They are biocompatible and can also be coated with biocompatible
surfactants, which may be further functionalized with optically and therapeutically
active molecules. These nanoparticles can be manipulated with non-invasive
external magnetic field to produce heat, target specific site, and monitor their
distribution in vivo. Within this framework, we have investigated a number of
biomedical applications of these nanoparticles. We synthesized a thermosensitive
microgel with iron oxide adsorbed on its surface. An alternating magnetic field
applied to these nanocomposites heated the system and triggered the release of an
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anticancer drug mitoxantrone . We also parameterized the chain length dependence
of drug release from dextran coated iron oxide nanoparticles, finding that both the
release rate and equilibrium release fraction depend on the molecular mass of the
surfactant. Finally, we also localized dextran coated iron oxide nanoparticles
labeled with tat peptide to the cell nucleus, which permits this system to be used for
a variety of biomedical applications.
Beyond investigating magnetic nanoparticles for biomedical applications, we
also studied their magnetohydrodynamic and dielectric properties in solution.
Magnetohydrodynamic properties of ferrofluid can be controlled by appropriate
selection of surfactant and deielctric measurement showed magnetodielectric
coupling in this system. We also established that some complex low temperature
spin structures are suppressed in Mn 3O4 nanoparticles, which has important
implications for nanomagnetic devices. Furthermore, we explored exchange bias
effects in Ni-NiO core-shell nanoparticles. Finally, we also performed extensive
magnetic studies in nickel metalhydride (NiMH) batteries to determine the size of
Ni clusters, which plays important role on catalyzing the electrochemical reaction
and powering Ni-MH batteries.
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